{
  "meta": {
    "id": "test1",
    "title": "Amino Acids",
    "category": "Subject Wise / Mixed"
  },
  "questions": [
    {
      "text": "Match the following metabolic disorders with their corresponding enzyme defect or deficiency:",
      "options": [
        {
          "label": "A",
          "text": "1-a, 2-b, 3-c, 4-d",
          "correct": false
        },
        {
          "label": "B",
          "text": "1-b, 2-a, 3-d, 4-c",
          "correct": true
        },
        {
          "label": "C",
          "text": "1-d, 2-c, 3-b, 4-a",
          "correct": false
        },
        {
          "label": "D",
          "text": "1-c, 2-b, 3-a, 4-d",
          "correct": false
        }
      ],
      "correct_answer": "B. 1-b, 2-a, 3-d, 4-c",
      "question_images": [
        "https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/04/03/screenshot-2024-04-03-173851.jpg"
      ],
      "explanation_images": [
        "https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/09/05/screenshot-2024-09-05-104916.jpeg",
        "https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/04/03/screenshot-2024-04-03-175323.jpg"
      ],
      "explanation": "<p><strong>Ans. B.</strong></p>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective:</li><li>\u27a4 Ref : DM Vasudevan 9/e: p 211, 221.</li><li>\u27a4 Ref</li><li>\u27a4 : DM Vasudevan 9/e: p 211, 221.</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "0643981e",
      "audio": ""
    },
    {
      "text": "A pediatrician is evaluating a newborn for potential metabolic disorders due to some concerning symptoms. Given the suspicion of phenylketonuria (PKU) among other metabolic conditions, the pediatrician considers the most effective screening method to identify such diseases in their early stages. Which screening test is considered the gold standard for detecting PKU and similar metabolic disorders in newborns?",
      "options": [
        {
          "label": "A",
          "text": "Western blot",
          "correct": false
        },
        {
          "label": "B",
          "text": "Electrophoresis",
          "correct": false
        },
        {
          "label": "C",
          "text": "FISH",
          "correct": false
        },
        {
          "label": "D",
          "text": "Tandem Mass spectrometry",
          "correct": true
        }
      ],
      "correct_answer": "D. Tandem Mass spectrometry",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. D.</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation</li><li>\u2022 :</li><li>\u2022 Option A. Western blot: Incorrect, as it's primarily used for protein analysis and not typically for newborn metabolic screening.</li><li>\u2022 Option</li><li>\u2022 A. Western blot:</li><li>\u2022 Option B. Electrophoresis: Incorrect, while it can separate molecules based on size and charge, it's not as comprehensive or specific for metabolic disorders as tandem mass spectrometry.</li><li>\u2022 Option B. Electrophoresis:</li><li>\u2022 Option C. FISH (Fluorescence In Situ Hybridization): Incorrect, as FISH is mainly used for detecting chromosomal abnormalities and gene mapping, not for screening metabolic disorders like PKU.</li><li>\u2022 Option</li><li>\u2022 C. FISH (Fluorescence In Situ Hybridization):</li></ul>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective:</li><li>\u27a4 Tandem Mass Spectrometry (MS/MS) is widely used in newborn screening programs for the detection of various metabolic disorders, including phenylketonuria (PKU). This method allows for the simultaneous screening of multiple disorders by analyzing patterns of specific metabolites in a small blood sample, usually obtained via heel prick in newborns. Its sensitivity and specificity make it an ideal choice for early detection.</li><li>\u27a4 Ref : DM Vasudevan 9/e :p 427</li><li>\u27a4 Ref : DM Vasudevan 9/e :p 427</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "c3d13386",
      "audio": ""
    },
    {
      "text": "During a routine neonatal examination, a newborn girl is noted to have blue eyes, blond hair, and fair skin. A Guthrie test is performed, yielding positive results. Among the following statements related to this case, which one is NOT true?",
      "options": [
        {
          "label": "A",
          "text": "Due to deficiency of enzyme Phenylalanine Hydroxylase",
          "correct": false
        },
        {
          "label": "B",
          "text": "Mental retardation is a potential complication",
          "correct": false
        },
        {
          "label": "C",
          "text": "Presence of a white patch of hair is due to a deficiency in tryptophan",
          "correct": true
        },
        {
          "label": "D",
          "text": "Phenylacetate is found in the urine",
          "correct": false
        }
      ],
      "correct_answer": "C. Presence of a white patch of hair is due to a deficiency in tryptophan",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. C. Presence of a white patch of hair is due to a deficiency in tryptophan</strong></p>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective:</li><li>\u27a4 Phenylketonuria results from phenylalanine hydroxylase deficiency, causing elevated phenylalanine levels and reduced tyrosine. The hypopigmentation seen in PKU patients is due to impaired melanin synthesis from reduced tyrosine availability\u2014not from tryptophan deficiency. Early detection through newborn screening and prompt dietary management are essential to prevent the neurological sequelae of this inborn error of metabolism.</li><li>\u27a4 Ref : Harper 30/e:  p 304-306</li><li>\u27a4 Ref</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "64b529a8",
      "audio": ""
    },
    {
      "text": "A 2-year-old boy is evaluated for severe mental retardation and recurrent seizures. His blood ammonia levels are normal, and there is no acidosis. Non-ketotic hyperglycinemia is diagnosed based on an elevated CSF/blood glycine ratio. Which of the following statements is false regarding this condition?",
      "options": [
        {
          "label": "A",
          "text": "Defect of glycine cleavage complex",
          "correct": false
        },
        {
          "label": "B",
          "text": "Effective management is available",
          "correct": true
        },
        {
          "label": "C",
          "text": "Also known as glycine encephalopathy",
          "correct": false
        },
        {
          "label": "D",
          "text": "Accumulation of neurotoxic intermediates are seen",
          "correct": false
        }
      ],
      "correct_answer": "B. Effective management is available",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. B.</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation :</li><li>\u2022 Option A. Defect of glycine cleavage complex: True , this is the underlying defect in non-ketotic hyperglycinemia.</li><li>\u2022 Option</li><li>\u2022 A. Defect of glycine cleavage complex:</li><li>\u2022 True</li><li>\u2022 Option C. Also known as glycine encephalopathy: True , this is another name for non-ketotic hyperglycinemia.</li><li>\u2022 Option</li><li>\u2022 C. Also known as glycine encephalopathy:</li><li>\u2022 True</li><li>\u2022 Option D. Accumulation of neurotoxic intermediates are seen: True , the accumulation of glycine and related compounds can lead to neurotoxicity.</li><li>\u2022 Option</li><li>\u2022 D. Accumulation of neurotoxic intermediates are seen:</li><li>\u2022 True</li></ul>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective:</li><li>\u27a4 Non-ketotic hyperglycinemia , also known as glycine encephalopathy , is a rare genetic disorder caused by a defect in the glycine cleavage enzyme complex , leading to an accumulation of glycine and its neurotoxic intermediates . Unfortunately, effective management options are limited, and the disease often results in severe neurological deficits.</li><li>\u27a4 Non-ketotic hyperglycinemia</li><li>\u27a4 glycine encephalopathy</li><li>\u27a4 rare genetic disorder</li><li>\u27a4 defect in the glycine cleavage enzyme complex</li><li>\u27a4 accumulation of glycine</li><li>\u27a4 neurotoxic intermediates</li><li>\u27a4 Ref : Harper 30/e: p 301, Vasudevan 9/ed: p 213.</li><li>\u27a4 Ref</li><li>\u27a4 : Harper 30/e: p 301, Vasudevan 9/ed: p 213.</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "b1158bc7",
      "audio": ""
    },
    {
      "text": "A 24-year-old researcher is studying the antioxidant defense mechanisms in the human body and is particularly interested in the role of glutathione. While reviewing the literature, he encounters various functions and characteristics of glutathione but finds conflicting information regarding one of its roles. Based on your knowledge, which of the following statements about glutathione (GSH) is NOT true?",
      "options": [
        {
          "label": "A",
          "text": "It is tripeptide",
          "correct": false
        },
        {
          "label": "B",
          "text": "It converts hemoglobin to methaemoglobin",
          "correct": true
        },
        {
          "label": "C",
          "text": "It conjugates xenobiotics (phase II)",
          "correct": false
        },
        {
          "label": "D",
          "text": "It is a cofactor of various enzymes",
          "correct": false
        }
      ],
      "correct_answer": "B. It converts hemoglobin to methaemoglobin",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. B.</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation</li><li>\u2022 :</li><li>\u2022 Option A. True, as glutathione is composed of three amino acids: glutamate, cysteine, and glycine.</li><li>\u2022 Option</li><li>\u2022 A. True, as glutathione is composed of three amino acids:</li><li>\u2022 Option C. True , glutathione plays a significant role in the detoxification process by conjugating with various xenobiotics, aiding in their excretion from the body.</li><li>\u2022 Option C. True</li><li>\u2022 Option D. True , glutathione acts as a cofactor for glutathione peroxidase and other enzymes involved in the reduction of peroxides and maintenance of redox status within cells.</li><li>\u2022 Option D. True</li></ul>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective:</li><li>\u27a4 G lutathione does not convert haemoglobin to methaemoglobin . Methaemoglobin formation occurs when the iron in hemoglobin is oxidized from the ferrous (Fe2+) to the ferric (Fe3+) state , which can happen through various mechanisms , but not directly due to glutathione. In fact, glutathione plays a role in reducing oxidative stress in cells and can help to protect against the oxidation of hemoglobin.</li><li>\u27a4 G</li><li>\u27a4 lutathione</li><li>\u27a4 not convert haemoglobin</li><li>\u27a4 methaemoglobin</li><li>\u27a4 Methaemoglobin formation</li><li>\u27a4 iron in hemoglobin</li><li>\u27a4 oxidized from the ferrous</li><li>\u27a4 ferric</li><li>\u27a4 state</li><li>\u27a4 various mechanisms</li><li>\u27a4 Ref : Harper 30/e: p 272-273.</li><li>\u27a4 Ref : Harper 30/e: p 272-273.</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "7ed81216",
      "audio": ""
    },
    {
      "text": "A 54-year-old woman presents to the outpatient department with a constellation of symptoms including flushing, a non-healing ulcer, diarrhea, and episodes of bronchospasm. Laboratory investigations reveal elevated levels of 5-Hydroxyindoleacetic Acid (5-HIAA) in her blood. Based on these findings, what is the most likely diagnosis?",
      "options": [
        {
          "label": "A",
          "text": "Glucagonoma",
          "correct": false
        },
        {
          "label": "B",
          "text": "Gastrinoma",
          "correct": false
        },
        {
          "label": "C",
          "text": "Carcinoid syndrome",
          "correct": true
        },
        {
          "label": "D",
          "text": "Insulinoma",
          "correct": false
        }
      ],
      "correct_answer": "C. Carcinoid syndrome",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. C.</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation</li><li>\u2022 :</li><li>\u2022 Option A Glucagonoma: Is a rare tumour of pancreatic alpha cells , resulting in overproduction of glucagon . It is associated with necrolytic migratory erythema, weight loss and diabetes mellitus.</li><li>\u2022 Option A Glucagonoma:</li><li>\u2022 rare tumour of pancreatic alpha cells</li><li>\u2022 overproduction of glucagon</li><li>\u2022 Option B. Gastrinoma: Is a gastrin secreting tumour of pancreas resulting in Zollinger-Ellison syndrome , where there is no feedback regulation of gastrin secretion causing very high level of gastric acid output along with high serum gastrin levels.</li><li>\u2022 Option B. Gastrinoma:</li><li>\u2022 gastrin secreting tumour</li><li>\u2022 pancreas</li><li>\u2022 Zollinger-Ellison syndrome</li><li>\u2022 Option D. Insulinoma: Is an Insulin secreting tumours characterized by constant high production of insulin (C-peptide) and decreased blood glucose by the tumour cells.</li><li>\u2022 Option D. Insulinoma:</li><li>\u2022 Insulin secreting tumours</li><li>\u2022 constant high production of insulin</li></ul>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective:</li><li>\u27a4 Carcinoid syndrome is characterized by a set of symptoms that include flushing, diarrhea, bronchospasm , and, in some cases, heart valve lesions . These symptoms are caused by the overproduction of serotonin by carcinoid tumors , most commonly originating in the gastrointestinal tract or lungs . Elevated levels of 5-Hydroxyindoleacetic Acid (5-HIAA), a metabolite of serotonin , in the urine or blood are a hallmark finding in carcinoid syndrome and support this diagnosis.</li><li>\u27a4 Carcinoid syndrome</li><li>\u27a4 set of symptoms</li><li>\u27a4 flushing, diarrhea, bronchospasm</li><li>\u27a4 heart valve lesions</li><li>\u27a4 overproduction of serotonin by carcinoid tumors</li><li>\u27a4 originating in the gastrointestinal tract or lungs</li><li>\u27a4 Elevated levels of 5-Hydroxyindoleacetic Acid</li><li>\u27a4 metabolite of serotonin</li><li>\u27a4 urine</li><li>\u27a4 blood</li><li>\u27a4 carcinoid syndrome</li><li>\u27a4 Ref : Harper 30/e: pg 557, DM Vasudevan  9/e: p 241-242</li><li>\u27a4 Ref : Harper 30/e: pg 557, DM Vasudevan  9/e: p 241-242</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "d7e1d6bc",
      "audio": ""
    },
    {
      "text": "A 7-year-old girl presents with progressive involuntary movements in her right hand and visual difficulties noted over the past year. Blood work reveals elevated serum homocysteine with normal liver, renal, thyroid function tests, and electrolytes. She responds favorably to high-dose pyridoxine and a methionine-restricted diet, with a noted improvement in dystonic movements after three months. What condition is most likely affecting this child?",
      "options": [
        {
          "label": "A",
          "text": "Hartnup\u2019s disease",
          "correct": false
        },
        {
          "label": "B",
          "text": "Cystinuria",
          "correct": false
        },
        {
          "label": "C",
          "text": "Classical Homocystinuria",
          "correct": true
        },
        {
          "label": "D",
          "text": "Cystathioninuria",
          "correct": false
        }
      ],
      "correct_answer": "C. Classical Homocystinuria",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. C.</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation</li><li>\u2022 :</li><li>\u2022 Option A. Hartnup\u2019s disease: Due to defective absorption of aromatic amino acids from intestine as well as reabsorption from renal tubules \u2192excretion of amino acids in urine.</li><li>\u2022 Option A. Hartnup\u2019s disease:</li><li>\u2022 defective absorption of aromatic amino acids</li><li>\u2022 intestine</li><li>\u2022 reabsorption from renal tubules</li><li>\u2022 Option B. Cystinuria: Due to defect/deficiency of transporter system \u2192patients cannot reabsorb cysteine into their bloodstream \u2192accumulation of cystine in urine forms stones \u2192leads to recurrent nephrolithiasis, obstruction, and finally renal failure.</li><li>\u2022 Option B. Cystinuria:</li><li>\u2022 defect/deficiency of transporter system</li><li>\u2022 bloodstream</li><li>\u2022 Option D. Cystathioninuria: Due to cystathionase deficiency , patient presents with mental retardation, anemia, thrombocytopenia and endocrinopathies.</li><li>\u2022 Option D. Cystathioninuria:</li><li>\u2022 cystathionase deficiency</li><li>\u2022 mental retardation, anemia, thrombocytopenia</li><li>\u2022 endocrinopathies.</li></ul>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective:</li><li>\u27a4 Classical homocystinuria is often due to a deficiency in the enzyme cystathionine \u03b2-synthase, leading to elevated homocysteine levels . Treatment with high-dose pyridoxine (vitamin B6), a cofactor for the enzyme , can improve symptoms , and a methionine-restricted diet can help manage homocysteine levels . The improvement in dystonia with treatment supports this diagnosis.</li><li>\u27a4 Classical homocystinuria</li><li>\u27a4 deficiency in the enzyme cystathionine \u03b2-synthase,</li><li>\u27a4 elevated homocysteine levels</li><li>\u27a4 high-dose pyridoxine</li><li>\u27a4 cofactor for the enzyme</li><li>\u27a4 improve symptoms</li><li>\u27a4 methionine-restricted diet</li><li>\u27a4 manage homocysteine levels</li><li>\u27a4 Ref : DM Vasudevan 9/e: p 221.</li><li>\u27a4 Ref</li><li>\u27a4 : DM Vasudevan 9/e: p 221.</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "e88a8a32",
      "audio": ""
    },
    {
      "text": "A 30-year-old woman with a diet lacking in fresh produce presents with recurrent infections and bruising. Considering her dietary insufficiency and clinical signs of compromised antioxidant defense, which set of amino acids is essential for the synthesis of the key antioxidant, glutathione?",
      "options": [
        {
          "label": "A",
          "text": "Glutamic acid, cystine, cysteine",
          "correct": false
        },
        {
          "label": "B",
          "text": "Glutamic acid, alanine, glycine",
          "correct": false
        },
        {
          "label": "C",
          "text": "Glutamic acid, cysteine, glycine",
          "correct": true
        },
        {
          "label": "D",
          "text": "Glutamic acid, cysteine, valine",
          "correct": false
        }
      ],
      "correct_answer": "C. Glutamic acid, cysteine, glycine",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. C.</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation</li><li>\u2022 :</li><li>\u2022 Option A. Glutamic acid, cystine, cysteine : Cystine is the oxidized dimer form of cysteine , and while it can be converted back to cysteine in the body , cystine itself is not directly used in glutathione synthesis.</li><li>\u2022 Option A. Glutamic acid, cystine, cysteine</li><li>\u2022 Cystine</li><li>\u2022 oxidized dimer form of cysteine</li><li>\u2022 converted back to cysteine in the body</li><li>\u2022 Option B. Glutamic acid, alanine, glycine : Alanine is not a component of glutathione .</li><li>\u2022 Option B. Glutamic acid, alanine, glycine</li><li>\u2022 Alanine</li><li>\u2022 not a component</li><li>\u2022 glutathione</li><li>\u2022 Option D. Glutamic acid, cysteine, valine : Valine is a branched-chain amino acid that is not involved in the synthesis of glutathione.</li><li>\u2022 Option D. Glutamic acid, cysteine, valine</li><li>\u2022 Valine</li><li>\u2022 branched-chain amino acid</li></ul>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective</li><li>\u27a4 :</li><li>\u27a4 Gamma glutamyl cysteinyl glycine ( Tripeptide : - SH group of cysteine is active part / reducing agent of GSH) reduction of methemoglobin (Fe 3+) to normal Hb (Fe 2+) It is involved in erythrocyte membrane integrity and in keeping enzymes in active state .</li><li>\u27a4 Gamma glutamyl cysteinyl glycine ( Tripeptide : - SH group of cysteine is active part / reducing agent of GSH) reduction of methemoglobin (Fe 3+) to normal Hb (Fe 2+)</li><li>\u27a4 Gamma glutamyl cysteinyl glycine</li><li>\u27a4 Tripeptide</li><li>\u27a4 reduction</li><li>\u27a4 methemoglobin</li><li>\u27a4 It is involved in erythrocyte membrane integrity and in keeping enzymes in active state .</li><li>\u27a4 involved in erythrocyte membrane integrity</li><li>\u27a4 keeping enzymes in active state</li><li>\u27a4 Ref : DM Vasudevan 9/e: p 44, 198.</li><li>\u27a4 Ref</li><li>\u27a4 : DM Vasudevan 9/e: p 44, 198.</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "7b141b58",
      "audio": ""
    },
    {
      "text": "A young girl presenting in the OPD is notably tall and thin, with slender fingers and dislocated lenses. Further investigation reveals a deficiency in cystathionine beta synthase. To manage her condition, which amino acid should be supplemented?",
      "options": [
        {
          "label": "A",
          "text": "Cysteine",
          "correct": true
        },
        {
          "label": "B",
          "text": "Methionine",
          "correct": false
        },
        {
          "label": "C",
          "text": "Serine",
          "correct": false
        },
        {
          "label": "D",
          "text": "Tyrosine",
          "correct": false
        }
      ],
      "correct_answer": "A. Cysteine",
      "question_images": [],
      "explanation_images": [
        "https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/04/03/screenshot-2024-04-03-172139_ub3dGS8.jpg"
      ],
      "explanation": "<p><strong>Ans. A. Cysteine</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation</li><li>\u2022 :</li><li>\u2022 Option B. Methionine: Incorrect, as supplementation could exacerbate the condition due to an already existing accumulation of homocysteine and methionine.</li><li>\u2022 Option</li><li>\u2022 B. Methionine:</li><li>\u2022 supplementation</li><li>\u2022 exacerbate the condition</li><li>\u2022 Option C. Serine: Incorrect, while serine is involved in one-carbon metabolism , it is not the primary amino acid affected in homocystinuria.</li><li>\u2022 Option</li><li>\u2022 C. Serine:</li><li>\u2022 one-carbon metabolism</li><li>\u2022 Option D. Tyrosine: Incorrect, as it is not directly involved in the metabolic pathway affected by cystathionine beta synthase deficiency.</li><li>\u2022 Option</li><li>\u2022 D. Tyrosine:</li><li>\u2022 not directly involved in the metabolic pathway</li></ul>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective:</li><li>\u27a4 Cystathionine beta synthase deficiency leads to classical homocystinuria , characterized by an inability to convert homocysteine to cystathionine , resulting in low levels of cysteine. Supplementing cysteine can help compensate for this deficiency and mitigate some of the disorder's metabolic effects.</li><li>\u27a4 Cystathionine beta synthase deficiency</li><li>\u27a4 classical homocystinuria</li><li>\u27a4 inability to convert homocysteine</li><li>\u27a4 cystathionine</li><li>\u27a4 low levels of cysteine.</li><li>\u27a4 Ref : DM Vasudevan 9/e: p 221.</li><li>\u27a4 Ref</li><li>\u27a4 : DM Vasudevan 9/e: p 221.</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "552fbc7b",
      "audio": ""
    },
    {
      "text": "In a clinical seminar focused on oxidative stress and cellular antioxidants, a biochemistry professor discusses the biochemical properties that enable glutathione to act as a potent antioxidant. One medical student asks about the specific functional group in glutathione that is primarily responsible for its antioxidant activity. Which of the following is the correct answer?",
      "options": [
        {
          "label": "A",
          "text": "Hydroxyl",
          "correct": false
        },
        {
          "label": "B",
          "text": "Sulfhydryl",
          "correct": true
        },
        {
          "label": "C",
          "text": "Carboxyl",
          "correct": false
        },
        {
          "label": "D",
          "text": "Guanidino",
          "correct": false
        }
      ],
      "correct_answer": "B. Sulfhydryl",
      "question_images": [],
      "explanation_images": [
        "https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/04/03/picture2_Hnk9zNj.jpg"
      ],
      "explanation": "<p><strong>Ans. B.</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation</li><li>\u2022 :</li><li>\u2022 Option A. Hydroxyl: Incorrect, as the hydroxyl group is not the primary reactive group in glutathione involved in antioxidant activity.</li><li>\u2022 Option</li><li>\u2022 A. Hydroxyl:</li><li>\u2022 hydroxyl group</li><li>\u2022 not the primary reactive group</li><li>\u2022 Option C. Carboxyl: Incorrect, the carboxyl group is a common functional group in many biomolecules but not the key reactive group in glutathione for its antioxidant function.</li><li>\u2022 Option</li><li>\u2022 C. Carboxyl:</li><li>\u2022 carboxyl group</li><li>\u2022 common functional group</li><li>\u2022 biomolecules</li><li>\u2022 Option D. Guanidino: Incorrect, the guanidino group is found in arginine and is not involved in the antioxidant activity of glutathione.</li><li>\u2022 Option</li><li>\u2022 D. Guanidino:</li><li>\u2022 guanidino group</li><li>\u2022 found in arginine</li></ul>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective:</li><li>\u27a4 The sulfhydryl (-SH) group in glutathione is crucial for its role as an antioxidant. This group, found in the cysteine residue of glutathione, is highly reactive and can donate a hydrogen atom to neutralize free radicals , making it essential for reducing oxidative stress in cells.</li><li>\u27a4 sulfhydryl</li><li>\u27a4 group</li><li>\u27a4 glutathione</li><li>\u27a4 role as an antioxidant.</li><li>\u27a4 found in the cysteine residue</li><li>\u27a4 glutathione,</li><li>\u27a4 highly reactive</li><li>\u27a4 donate a hydrogen atom</li><li>\u27a4 neutralize free radicals</li><li>\u27a4 Ref : DM Vasudevan 9/e: p 133,212,217,218.</li><li>\u27a4 Ref</li><li>\u27a4 : DM Vasudevan 9/e: p 133,212,217,218.</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "cd51cce7",
      "audio": ""
    },
    {
      "text": "Which of the following statements about glycine is true?",
      "options": [
        {
          "label": "A",
          "text": "Glycine is an essential amino acid",
          "correct": false
        },
        {
          "label": "B",
          "text": "Sulphur present at 4 th position",
          "correct": false
        },
        {
          "label": "C",
          "text": "Has a guanidine group",
          "correct": false
        },
        {
          "label": "D",
          "text": "Optically inactive",
          "correct": true
        }
      ],
      "correct_answer": "D. Optically inactive",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. D. Optically inactive</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation</li><li>\u2022 :</li><li>\u2022 Option A. Glycine is not an essential amino acid; the human body can synthesize it.</li><li>\u2022 Option</li><li>\u2022 A.</li><li>\u2022 Glycine</li><li>\u2022 not an essential amino acid;</li><li>\u2022 Option B. Sulfur at the 4th position describes certain other amino acids like cysteine , but not glycine.</li><li>\u2022 Option</li><li>\u2022 B.</li><li>\u2022 Sulfur</li><li>\u2022 4th position</li><li>\u2022 amino acids like cysteine</li><li>\u2022 Option C. A guanidine group is characteristic of arginine, not glycine.</li><li>\u2022 Option</li><li>\u2022 C.</li><li>\u2022 guanidine group</li><li>\u2022 arginine,</li></ul>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective:</li><li>\u27a4 Glycine is unique among amino acids because it has a hydrogen atom as its side chain , making it the simplest amino acid. This simplicity leads to its lack of a chiral centre , rendering it optically inactive , unlike most other amino acids that are optically active due to the presence of a chiral carbon atom.</li><li>\u27a4 Glycine</li><li>\u27a4 unique among amino acids</li><li>\u27a4 hydrogen atom as its side chain</li><li>\u27a4 simplest amino acid.</li><li>\u27a4 simplicity leads</li><li>\u27a4 lack of a chiral centre</li><li>\u27a4 rendering</li><li>\u27a4 optically inactive</li><li>\u27a4 amino acids that are optically active</li><li>\u27a4 presence of a chiral carbon atom.</li><li>\u27a4 Ref : Harper 30/e p19.</li><li>\u27a4 Ref</li><li>\u27a4 : Harper 30/e p19.</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "e2472013",
      "audio": ""
    },
    {
      "text": "A 75-year-old man with a history of myocardial infarctions and cerebrovascular accidents presents for a follow-up. His laboratory results indicate elevated homocysteine levels, which decrease following treatment with pharmacological doses of pyridoxamine. Considering the effect of pyridoxamine on homocysteine levels, which enzyme's activity is most likely enhanced by this treatment?",
      "options": [
        {
          "label": "A",
          "text": "Methionine synthase",
          "correct": false
        },
        {
          "label": "B",
          "text": "N5, N10 methylenetetrahydrofolate reductase",
          "correct": false
        },
        {
          "label": "C",
          "text": "Cystathionine \u03b2-synthase",
          "correct": true
        },
        {
          "label": "D",
          "text": "Cystathionase",
          "correct": false
        }
      ],
      "correct_answer": "C. Cystathionine \u03b2-synthase",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. C.</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation</li><li>\u2022 :</li><li>\u2022 Option A. Methionine synthase: Defect in methionine synthase will cause elevated homocysteine levels and it requires B 12 not B 6 .</li><li>\u2022 Option A. Methionine synthase:</li><li>\u2022 Defect</li><li>\u2022 methionine synthase</li><li>\u2022 elevated homocysteine levels</li><li>\u2022 B 12 not B 6 .</li><li>\u2022 Option B. N5, N10 methylenetetrahydrofolate reductase: A defect in this enzyme leads to elevated homocysteine but that enzyme has a requirement for NADH not vitamin B 6.</li><li>\u2022 Option B. N5, N10 methylenetetrahydrofolate reductase:</li><li>\u2022 defect in this enzyme</li><li>\u2022 elevated homocysteine</li><li>\u2022 Option D. Cystathionase: A defect in cystathionase (another B 6 requiring enzyme) will block the degradation of cystathionine \u2192 accumulation of the same but will not lead to significantly elevated homocysteine.</li><li>\u2022 Option D. Cystathionase:</li><li>\u2022 defect in cystathionase</li><li>\u2022 block the degradation of cystathionine</li><li>\u2022 accumulation of the same</li></ul>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective:</li><li>\u27a4 Pyridoxamine, a form of vitamin B6 , serves as a cofactor for cystathionine \u03b2-synthase , an enzyme involved in the transsulfuration pathway that converts homocysteine to cystathionine . Supplementation with pyridoxamine can enhance the activity of this enzyme , thereby reducing homocysteine levels in the blood .</li><li>\u27a4 Pyridoxamine,</li><li>\u27a4 form of vitamin B6</li><li>\u27a4 cofactor for cystathionine \u03b2-synthase</li><li>\u27a4 enzyme</li><li>\u27a4 transsulfuration pathway</li><li>\u27a4 converts homocysteine</li><li>\u27a4 to cystathionine</li><li>\u27a4 Supplementation</li><li>\u27a4 pyridoxamine</li><li>\u27a4 enhance the activity</li><li>\u27a4 enzyme</li><li>\u27a4 reducing homocysteine levels in the blood</li><li>\u27a4 Ref : DM Vasudevan 9/e: p 221.</li><li>\u27a4 Ref : DM Vasudevan 9/e: p 221.</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "1b3dd4b4",
      "audio": ""
    },
    {
      "text": "An 18-year-old male is brought to the emergency department with acute left flank pain extending to the pubic area. He has reddish-brown urine, and urinalysis reveals numerous red blood cells. Upon acidifying his urine with acetic acid, flat, hexagonal transparent crystals are observed. Abdominal X-ray shows radiopaque stones in both kidneys, and a passed stone is predominantly composed of cysteine. Based on this presentation, which of the following is the most appropriate treatment suggestion?",
      "options": [
        {
          "label": "A",
          "text": "Increased ethanol consumption",
          "correct": false
        },
        {
          "label": "B",
          "text": "Restriction of dietary methionine",
          "correct": true
        },
        {
          "label": "C",
          "text": "Utilize drugs that acidify the urine",
          "correct": false
        },
        {
          "label": "D",
          "text": "Restrict dietary glycine",
          "correct": false
        }
      ],
      "correct_answer": "B. Restriction of dietary methionine",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. B.</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation</li><li>\u2022 :</li><li>\u2022 Option A. Increasing ethanol content causes dehydration , which will increase the concentration of cysteine in the urine, leading to increased precipitation.</li><li>\u2022 Option A.</li><li>\u2022 Increasing ethanol</li><li>\u2022 dehydration</li><li>\u2022 Option C. Acidification also reduces the solubility of the cysteine stones, alkalinization of urine is usually recommended to increase cystine solubility.</li><li>\u2022 Option C.</li><li>\u2022 Acidification</li><li>\u2022 reduces the solubility</li><li>\u2022 cysteine stones, alkalinization</li><li>\u2022 urine</li><li>\u2022 Option D. Restricting glycine is not effective, as glycine is not a precursor of cysteine biosynthesis.</li><li>\u2022 Option D.</li><li>\u2022 Restricting glycine</li></ul>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective:</li><li>\u27a4 Cystinuria - a genetic condition characterized by the excessive excretion of cystine in the urine, leading to stone formation. Cysteine is a product of methionine metabolism ; thus, restricting dietary methionine can help reduce cystine levels in the urine and prevent further stone formation.</li><li>\u27a4 Cystinuria</li><li>\u27a4 genetic condition</li><li>\u27a4 excessive excretion</li><li>\u27a4 cystine in the urine,</li><li>\u27a4 stone formation.</li><li>\u27a4 Cysteine</li><li>\u27a4 product of methionine metabolism</li><li>\u27a4 restricting dietary methionine</li><li>\u27a4 reduce cystine levels</li><li>\u27a4 urine</li><li>\u27a4 stone formation.</li><li>\u27a4 Ref : DM Vasudevan 9/e: p 219.</li><li>\u27a4 Ref : DM Vasudevan 9/e: p 219.</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "cb42d30e",
      "audio": ""
    },
    {
      "text": "A 13-year-old boy presents with flank pain and difficulty urinating. Kidney stone analysis reveals calcium oxalate composition. His parents have a history of similar issues. The accumulation of oxalate in this patient suggests a metabolic challenge with which of the following substances?",
      "options": [
        {
          "label": "A",
          "text": "Alanine",
          "correct": false
        },
        {
          "label": "B",
          "text": "Leucine",
          "correct": false
        },
        {
          "label": "C",
          "text": "Lysine",
          "correct": false
        },
        {
          "label": "D",
          "text": "Glyoxylate",
          "correct": true
        }
      ],
      "correct_answer": "D. Glyoxylate",
      "question_images": [],
      "explanation_images": [
        "https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/04/03/picture3_7pTOWMv.jpg"
      ],
      "explanation": "<p><strong>Ans. D. Glyoxylate</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation</li><li>\u2022 :</li><li>\u2022 Option A. Alanine: Incorrect, as alanine metabolism disruptions are not typically associated with oxalate stone formation.</li><li>\u2022 Option</li><li>\u2022 A. Alanine:</li><li>\u2022 alanine metabolism disruptions</li><li>\u2022 not</li><li>\u2022 oxalate stone formation.</li><li>\u2022 Option B. Leucine: Incorrect, as leucine metabolism defects are more commonly linked to maple syrup urine disease and not directly to oxalate stone formation.</li><li>\u2022 Option</li><li>\u2022 B. Leucine:</li><li>\u2022 leucine metabolism</li><li>\u2022 linked to maple syrup urine disease</li><li>\u2022 Option C. Lysine: Incorrect, as lysine's metabolic pathway does not directly result in oxalate accumulation.</li><li>\u2022 Option</li><li>\u2022 C. Lysine:</li><li>\u2022 lysine's metabolic pathway</li></ul>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective:</li><li>\u27a4 Calcium oxalate stone formation can be linked to a disorder in glyoxylate metabolism . When glyoxylate is not properly metabolized, it can be converted to oxalate , which then combines with calcium to form calcium oxalate stones. This condition, often inherited, leads to recurrent stone formation and can be indicative of a primary hyperoxaluria type.</li><li>\u27a4 Calcium oxalate stone formation</li><li>\u27a4 linked to a disorder in glyoxylate metabolism</li><li>\u27a4 glyoxylate</li><li>\u27a4 not properly metabolized,</li><li>\u27a4 converted to oxalate</li><li>\u27a4 combines with calcium</li><li>\u27a4 form calcium oxalate stones.</li><li>\u27a4 Ref : DM Vasudevan 9/e: p 213.</li><li>\u27a4 Ref</li><li>\u27a4 : DM Vasudevan 9/e: p 213.</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "83b0a018",
      "audio": ""
    },
    {
      "text": "Which enzyme is pivotal in the glycine cleavage system found in liver mitochondria?",
      "options": [
        {
          "label": "A",
          "text": "Glycine Dehydrogenase",
          "correct": true
        },
        {
          "label": "B",
          "text": "Glycine Transaminase",
          "correct": false
        },
        {
          "label": "C",
          "text": "Glycine carboxylase",
          "correct": false
        },
        {
          "label": "D",
          "text": "Glycine Dehydratase",
          "correct": false
        }
      ],
      "correct_answer": "A. Glycine Dehydrogenase",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. A. Glycine Dehydrogenase</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation</li><li>\u2022 :</li><li>\u2022 Option B. Glycine Transaminase: Incorrect, as this enzyme is involved in the transamination reactions , not the cleavage of glycine.</li><li>\u2022 Option</li><li>\u2022 B. Glycine Transaminase:</li><li>\u2022 enzyme</li><li>\u2022 transamination reactions</li><li>\u2022 Option C. Glycine Carboxylase: Incorrect, as there is no enzyme specifically named glycine carboxylase involved in the glycine cleavage system.</li><li>\u2022 Option</li><li>\u2022 C. Glycine Carboxylase:</li><li>\u2022 no enzyme</li><li>\u2022 glycine carboxylase</li><li>\u2022 glycine cleavage system.</li><li>\u2022 Option D. Glycine Dehydratase: Incorrect, as this name does not correspond to the primary enzyme in the glycine cleavage system.</li><li>\u2022 Option</li><li>\u2022 D. Glycine Dehydratase:</li><li>\u2022 name does not correspond to the primary enzyme</li></ul>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective:</li><li>\u27a4 The glycine cleavage system , a complex enzyme system found in liver mitochondria and other tissues, primarily involves Glycine Dehydrogenase (also known as P protein). This enzyme plays a crucial role in the breakdown of glycine , facilitating its conversion into smaller molecules that can be used in various metabolic pathways .</li><li>\u27a4 glycine cleavage system</li><li>\u27a4 complex enzyme system</li><li>\u27a4 liver mitochondria</li><li>\u27a4 other tissues,</li><li>\u27a4 Glycine Dehydrogenase</li><li>\u27a4 enzyme</li><li>\u27a4 crucial role in the breakdown of glycine</li><li>\u27a4 facilitating its conversion</li><li>\u27a4 smaller molecules</li><li>\u27a4 various metabolic pathways</li><li>\u27a4 Ref : Harper 30/e p302.</li><li>\u27a4 Ref : Harper 30/e p302.</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "27a14cb4",
      "audio": ""
    },
    {
      "text": "During a workshop on nutritional supplements and their therapeutic uses, a health coach discusses the benefits of N-acetyl cysteine (NAC) in supporting the body's antioxidant systems. One attendee, a fitness enthusiast who's keen on optimizing her recovery times and overall health through nutrition, inquires about the specific compound that NAC helps to replenish in the body, enhancing its antioxidant defenses. What should the health coach respond?",
      "options": [
        {
          "label": "A",
          "text": "Glutathione",
          "correct": true
        },
        {
          "label": "B",
          "text": "Glycine",
          "correct": false
        },
        {
          "label": "C",
          "text": "Glutamate",
          "correct": false
        },
        {
          "label": "D",
          "text": "GABA",
          "correct": false
        }
      ],
      "correct_answer": "A. Glutathione",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. A. Glutathione</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation</li><li>\u2022 :</li><li>\u2022 Option B. Glycine: Incorrect, as NAC directly influences glutathione levels rather than glycine.</li><li>\u2022 Option</li><li>\u2022 B. Glycine:</li><li>\u2022 NAC directly influences glutathione levels</li><li>\u2022 Option C. Glutamate: Incorrect, glutamate is a neurotransmitter and not the primary compound replenished by NAC.</li><li>\u2022 Option</li><li>\u2022 C. Glutamate:</li><li>\u2022 glutamate</li><li>\u2022 neurotransmitter</li><li>\u2022 not the primary compound</li><li>\u2022 Option D. GABA: Incorrect, GABA (Gamma-Aminobutyric Acid) is also a neurotransmitter and not directly affected by NAC supplementation .</li><li>\u2022 Option</li><li>\u2022 D. GABA:</li><li>\u2022 GABA</li><li>\u2022 neurotransmitter</li><li>\u2022 not directly</li><li>\u2022 NAC supplementation</li></ul>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective:</li><li>\u27a4 N-acetyl cysteine (NAC) is a precursor to glutathione , one of the body's most powerful antioxidants . By replenishing intracellular levels of glutathione , NAC supports the body's ability to neutralize free radicals and reduce oxidative stress , which is particularly beneficial for athletes and those engaged in regular intense physical activity.</li><li>\u27a4 N-acetyl cysteine</li><li>\u27a4 precursor to glutathione</li><li>\u27a4 body's most powerful antioxidants</li><li>\u27a4 replenishing intracellular levels</li><li>\u27a4 glutathione</li><li>\u27a4 NAC supports</li><li>\u27a4 body's ability to neutralize free radicals</li><li>\u27a4 reduce oxidative stress</li><li>\u27a4 Ref : DM Vasudevan 9/e: p 228.</li><li>\u27a4 Ref : DM Vasudevan 9/e: p 228.</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "ba664d5d",
      "audio": ""
    },
    {
      "text": "In a university's biochemistry department, a group of students is preparing a presentation on rare metabolic disorders for an upcoming conference. One of the topics they are focusing on is Primary Oxaluria, specifically the less common type II variant. They delve into the underlying metabolic defect responsible for this condition. Which enzyme's malfunction is implicated in Primary Oxaluria type II?",
      "options": [
        {
          "label": "A",
          "text": "Glycine cleavage system",
          "correct": false
        },
        {
          "label": "B",
          "text": "Alanine Glyoxylate Aminotransferase",
          "correct": false
        },
        {
          "label": "C",
          "text": "D-Glycerate Dehydrogenase",
          "correct": true
        },
        {
          "label": "D",
          "text": "Excess Vitamin C",
          "correct": false
        }
      ],
      "correct_answer": "C. D-Glycerate Dehydrogenase",
      "question_images": [],
      "explanation_images": [
        "https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/04/03/picture4_gwtTMYX.jpg"
      ],
      "explanation": "<p><strong>Ans. C.</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation</li><li>\u2022 :</li><li>\u2022 Option A. Glycine cleavage system: Incorrect, as defects in this system are associated with conditions like Non-ketotic Hyperglycinemia rather than Primary Oxaluria.</li><li>\u2022 Option A.</li><li>\u2022 Glycine cleavage system:</li><li>\u2022 defects in this system</li><li>\u2022 Non-ketotic Hyperglycinemia</li><li>\u2022 Option B. Alanine Glyoxylate Aminotransferase: Incorrect, this enzyme's deficiency is linked to Primary Oxaluria type I , not type II.</li><li>\u2022 Option</li><li>\u2022 B. Alanine Glyoxylate Aminotransferase:</li><li>\u2022 enzyme's deficiency</li><li>\u2022 linked to Primary Oxaluria type I</li><li>\u2022 Option D. Excess Vitamin C: Incorrect, while excessive vitamin C can contribute to oxalate formation , it is not the underlying cause of Primary Oxaluria type II.</li><li>\u2022 Option</li><li>\u2022 D. Excess Vitamin C:</li><li>\u2022 excessive vitamin C can contribute to oxalate formation</li></ul>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective:</li><li>\u27a4 Primary Oxaluria type II is caused by a deficiency in D-Glycerate Dehydrogenase, an enzyme involved in the glyoxylate and hydroxypyruvate metabolism . This defect leads to the accumulation of oxalate and L-glycerate, contributing to the formation of kidney stones and other related symptoms.</li><li>\u27a4 Primary Oxaluria type II</li><li>\u27a4 deficiency in D-Glycerate Dehydrogenase,</li><li>\u27a4 enzyme involved in the glyoxylate</li><li>\u27a4 hydroxypyruvate metabolism</li><li>\u27a4 leads to the accumulation of oxalate</li><li>\u27a4 L-glycerate,</li><li>\u27a4 Ref: DM Vasudevan 9/e: p 213.</li><li>\u27a4 Ref: DM Vasudevan 9/e: p 213.</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "08312271",
      "audio": ""
    },
    {
      "text": "A 12-year-old boy is brought to the outpatient department by his parents due to concerns about his behavioral problems. Upon examination, the physician notes several physical anomalies: brittle and coarse hair, red patches on the skin, disproportionately long and thin arms and legs, scoliosis, a displaced lens, and muscular hypotonia. Given these clinical findings, which metabolite is most likely to be elevated in this patient's blood work?",
      "options": [
        {
          "label": "A",
          "text": "Methionine",
          "correct": false
        },
        {
          "label": "B",
          "text": "Phenylpyruvate",
          "correct": false
        },
        {
          "label": "C",
          "text": "Fibrillin",
          "correct": false
        },
        {
          "label": "D",
          "text": "Homocysteine",
          "correct": true
        }
      ],
      "correct_answer": "D. Homocysteine",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. D. Homocysteine</strong></p>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective:</li><li>\u27a4 Homocystinuria due to cystathionine \u03b2-synthase deficiency presents with a constellation of findings including ectopia lentis, Marfanoid habitus (tall, thin build with long extremities), skeletal abnormalities, and neurodevelopmental issues. The biochemical hallmark is elevated homocysteine, which can be detected in blood and urine testing. Early diagnosis and treatment with vitamin B6 (pyridoxine), betaine, methionine restriction, and cysteine supplementation may prevent or minimize complications.</li><li>\u27a4 Ref : DM Vasudevan 9/e: p 221.</li><li>\u27a4 Ref</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "12fa611d",
      "audio": ""
    },
    {
      "text": "A 15-year-old boy diagnosed with homocystinuria is under evaluation for treatment options that could help manage his condition. Given the enzymatic deficiencies associated with homocystinuria, the healthcare team considers vitamin supplementation as part of his treatment plan. Which vitamin is most likely to be effective in controlling this metabolic disorder?",
      "options": [
        {
          "label": "A",
          "text": "B 1",
          "correct": false
        },
        {
          "label": "B",
          "text": "B 2",
          "correct": false
        },
        {
          "label": "C",
          "text": "B 3",
          "correct": false
        },
        {
          "label": "D",
          "text": "B 6",
          "correct": true
        }
      ],
      "correct_answer": "D. B 6",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. D. B6</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation</li><li>\u2022 :</li><li>\u2022 Option A. B1 (Thiamine): Incorrect, as thiamine does not play a direct role in the treatment of homocystinuria.</li><li>\u2022 Option</li><li>\u2022 A. B1 (Thiamine):</li><li>\u2022 thiamine</li><li>\u2022 not play a direct role in the treatment of homocystinuria.</li><li>\u2022 Option B. B2 (Riboflavin): Incorrect, riboflavin is not the primary vitamin used in the management of homocystinuria.</li><li>\u2022 Option</li><li>\u2022 B. B2 (Riboflavin):</li><li>\u2022 riboflavin</li><li>\u2022 not the primary vitamin</li><li>\u2022 management of homocystinuria.</li><li>\u2022 Option C. B3 (Niacin): Incorrect, niacin is not involved in the metabolic pathways affected by homocystinuria.</li><li>\u2022 Option</li><li>\u2022 C. B3 (Niacin):</li><li>\u2022 not involved</li><li>\u2022 metabolic pathways</li><li>\u2022 homocystinuria.</li></ul>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective:</li><li>\u27a4 Homocystinuria , often due to a deficiency in the enzyme cystathionine \u03b2-synthase , can sometimes be responsive to high doses of vitamin B6 (pyridoxine). Vitamin B6 serves as a cofactor for cystathionine \u03b2-synthase , and supplementation can enhance the residual activity of the enzyme in some patients, thereby reducing homocysteine levels and mitigating the risk of complications associated with the disorder.</li><li>\u27a4 Homocystinuria</li><li>\u27a4 deficiency in the enzyme cystathionine \u03b2-synthase</li><li>\u27a4 responsive to high doses of vitamin B6</li><li>\u27a4 Vitamin B6</li><li>\u27a4 cofactor for cystathionine \u03b2-synthase</li><li>\u27a4 supplementation</li><li>\u27a4 enhance the residual activity of the enzyme</li><li>\u27a4 reducing homocysteine levels</li><li>\u27a4 Ref : DM Vasudevan 9/e: p 221.</li><li>\u27a4 Ref : DM Vasudevan 9/e: p 221.</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "d44a5b07",
      "audio": ""
    },
    {
      "text": "A 28-year-old marathon runner visits a sports medicine clinic complaining of prolonged recovery times after long training sessions. She's interested in optimizing her nutrition to enhance muscle repair and overall performance. Her recent blood work showed slightly elevated homocysteine levels. The physician decides to focus on her dietary intake, specifically the vitamins involved in the metabolism of sulfur-containing amino acids, which are crucial for muscle recovery. Which vitamins should the physician consider crucial in this metabolic pathway to address the runner's concerns and blood work findings?",
      "options": [
        {
          "label": "A",
          "text": "Vitamin B 12",
          "correct": false
        },
        {
          "label": "B",
          "text": "Folic acid",
          "correct": false
        },
        {
          "label": "C",
          "text": "Vitamin K",
          "correct": false
        },
        {
          "label": "D",
          "text": "Both a and b",
          "correct": true
        }
      ],
      "correct_answer": "D. Both a and b",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. D. Both a and b</strong></p>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective:</li><li>\u27a4 Vitamin B12 and folic acid play pivotal roles in the metabolism of sulfur-containing amino acids . Vitamin B12 is involved in the conversion of homocysteine to methionine, while folic acid is essential for the remethylation of homocysteine , also contributing to its conversion back to methionine . These processes are crucial for maintaining low levels of homocysteine, high levels of which are associated with cardiovascular diseases.</li><li>\u27a4 Vitamin B12</li><li>\u27a4 folic acid</li><li>\u27a4 pivotal roles in the metabolism of sulfur-containing amino acids</li><li>\u27a4 Vitamin B12</li><li>\u27a4 conversion of homocysteine to methionine,</li><li>\u27a4 folic acid</li><li>\u27a4 remethylation of homocysteine</li><li>\u27a4 conversion back to methionine</li><li>\u27a4 Ref : DM Vasudevan 9/e: p 216.</li><li>\u27a4 Ref</li><li>\u27a4 : DM Vasudevan 9/e: p 216.</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "3ea81287",
      "audio": ""
    },
    {
      "text": "A 45-year-old woman presents with progressive palmoplantar, nose & pinna pigmentation. Urine sample collected for benedict's test changes to black in the supernatant and the test gives greenish brown precipitate. What is the diagnosis?",
      "options": [
        {
          "label": "A",
          "text": "Phenylketonuria",
          "correct": false
        },
        {
          "label": "B",
          "text": "Alkaptonuria",
          "correct": true
        },
        {
          "label": "C",
          "text": "Tyrosinemia type 2",
          "correct": false
        },
        {
          "label": "D",
          "text": "Argininosuccinic aciduria",
          "correct": false
        }
      ],
      "correct_answer": "B. Alkaptonuria",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. B.</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation</li><li>\u2022 :</li><li>\u2022 Option A. Phenylketonuria: Deficiency of phenylalanine hydroxylase ; C/F - mentally retardation, agitation, hyperactivity, tremors & convulsions due to interference of phenylalanine with neurotransmitter synthesis & hypopigmentation (inhibition of tyrosinase)</li><li>\u2022 Option A. Phenylketonuria:</li><li>\u2022 Deficiency</li><li>\u2022 phenylalanine hydroxylase</li><li>\u2022 Option C. Tyrosinemia type-2: Deficiency of tyrosine transaminase ; C/F -Mental retardation, painful corneal lesions, photophobia and keratosis of palmar surface with increased urinary excretion of tyrosine and tyramine.</li><li>\u2022 Option C. Tyrosinemia type-2:</li><li>\u2022 Deficiency</li><li>\u2022 tyrosine transaminase</li><li>\u2022 Option D. Argininosuccinic aciduria: Deficiency of argininosuccinate lyase with hyperammonemia and elevated argininosuccinate in CSF and excretion in urine and friable tufted hair (trichorrhexis nodosa).</li><li>\u2022 Option D. Argininosuccinic aciduria:</li><li>\u2022 Deficiency</li><li>\u2022 argininosuccinate lyase</li><li>\u2022 hyperammonemia</li><li>\u2022 elevated argininosuccinate</li><li>\u2022 CSF</li></ul>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective:</li><li>\u27a4 Alkaptonuria is a rare metabolic disorder characterized by the accumulation of homogentisic acid , leading to its oxidation and polymerization, particularly in connective tissues (a condition known as ochronosis), resulting in dark pigmentation . The urine turning black upon standing or after adding an alkalizing agent (in this case, noted during a Benedict's test) is a hallmark sign of this condition.</li><li>\u27a4 Alkaptonuria</li><li>\u27a4 rare metabolic disorder</li><li>\u27a4 accumulation of homogentisic acid</li><li>\u27a4 oxidation</li><li>\u27a4 polymerization,</li><li>\u27a4 connective tissues</li><li>\u27a4 dark pigmentation</li><li>\u27a4 Ref : Harper 30/e: p 304-305, Lippincott 7/e: P 274.</li><li>\u27a4 Ref : Harper 30/e: p 304-305, Lippincott 7/e: P 274.</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "fbc40033",
      "audio": ""
    },
    {
      "text": "A concerned mother brings her 2-month-old infant to the pediatric clinic, reporting that the baby's urine has a distinct cabbage-like odor. This unusual symptom prompts the pediatrician to consider metabolic disorders that could be associated with such an olfactory finding. Based on the described symptom, what is the most probable diagnosis for this infant?",
      "options": [
        {
          "label": "A",
          "text": "Leucine catabolism defect",
          "correct": false
        },
        {
          "label": "B",
          "text": "Hawkinsinuria",
          "correct": false
        },
        {
          "label": "C",
          "text": "Tyrosinemia type 1",
          "correct": true
        },
        {
          "label": "D",
          "text": "Maple syrup urine disease",
          "correct": false
        }
      ],
      "correct_answer": "C. Tyrosinemia type 1",
      "question_images": [],
      "explanation_images": [
        "https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/04/04/screenshot-2024-04-04-100432.jpg"
      ],
      "explanation": "<p><strong>Ans. C.</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation</li><li>\u2022 :</li><li>\u2022 Option A. Leucine catabolism defect: Incorrect, as defects in leucine metabolism typically lead to the odor of maple syrup in the urine, not cabbage.</li><li>\u2022 Option</li><li>\u2022 A. Leucine catabolism defect:</li><li>\u2022 defects in leucine metabolism</li><li>\u2022 Option B. Hawkinsinuria: Incorrect, as this very rare metabolic disorder does not typically present with cabbage odor urine.</li><li>\u2022 Option</li><li>\u2022 B. Hawkinsinuria:</li><li>\u2022 very rare metabolic disorder</li><li>\u2022 Option D. Maple syrup urine disease: Incorrect, as the characteristic odor associated with this disorder is sweet or burnt sugar , resembling maple syrup, not cabbage.</li><li>\u2022 Option</li><li>\u2022 D. Maple syrup urine disease:</li><li>\u2022 odor</li><li>\u2022 disorder is sweet or burnt sugar</li></ul>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective:</li><li>\u27a4 Ref : Harper 30/e: p 304-307, DM Vasudevan  9/e: p 239,240</li><li>\u27a4 Ref</li><li>\u27a4 : Harper 30/e: p 304-307, DM Vasudevan  9/e: p 239,240</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "e055de76",
      "audio": ""
    },
    {
      "text": "A 10-year-old girl presents with a history of mild mental retardation, episodes of vomiting, lethargy, seizures, and hypertonia that were first noted during the initial week of life. Amino acid screening reveals elevated levels of leucine, isoleucine, and valine. Based on these findings, which enzyme is likely deficient in this patient?",
      "options": [
        {
          "label": "A",
          "text": "Branched chain ketoacid dehydrogenase",
          "correct": true
        },
        {
          "label": "B",
          "text": "Cystathionine synthase",
          "correct": false
        },
        {
          "label": "C",
          "text": "Ornithine transcarbamylase",
          "correct": false
        },
        {
          "label": "D",
          "text": "Methyl malonyl CoA mutase",
          "correct": false
        }
      ],
      "correct_answer": "A. Branched chain ketoacid dehydrogenase",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. A.</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation</li><li>\u2022 :</li><li>\u2022 Option B. Cystathionine synthase: Congenital homocystinuria , C/F-Mental retardation, Ectopia lentis, Thrombosis and Charlie Chaplin gait.</li><li>\u2022 Option B. Cystathionine synthase:</li><li>\u2022 Congenital homocystinuria</li><li>\u2022 Option C. Ornithine transcarbamylase: The only urea cycle disorder with X-linked trait. C/F- Hyperammonaemia, elevated levels of ammonia are associated with high glutamine levels in CSF and blood in the affected child. Mothers also have hyperammonaemia and an aversion to high protein diet.</li><li>\u2022 Option C. Ornithine transcarbamylase:</li><li>\u2022 urea cycle disorder</li><li>\u2022 X-linked trait.</li><li>\u2022 Option D. Methylmalonyl CoA mutase: Methylmalonic Aciduria . C/F- MR, ketosis, hypotonia, Blood-methyl malonic acid is elevated and in urine -methyl maIonic acid and ketone bodies are seen. Treatment \u2013Vitamin B12.</li><li>\u2022 Option D. Methylmalonyl CoA mutase:</li><li>\u2022 Methylmalonic Aciduria</li></ul>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective:</li><li>\u27a4 The elevated levels of leucine , isoleucine , and valine indicate Maple Syrup Urine Disease (MSUD), which is caused by a deficiency in the branched chain ketoacid dehydrogenase complex.</li><li>\u27a4 elevated levels of leucine</li><li>\u27a4 isoleucine</li><li>\u27a4 valine</li><li>\u27a4 Maple Syrup Urine Disease</li><li>\u27a4 deficiency in the branched chain ketoacid dehydrogenase complex.</li><li>\u27a4 Ref : Harper 30/e:  p 309-311.</li><li>\u27a4 Ref</li><li>\u27a4 : Harper 30/e:  p 309-311.</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "4f75a463",
      "audio": ""
    },
    {
      "text": "A 2-year-old child is brought to the clinic with symptoms resembling pellagra, including dermatitis, ataxia, and neuropsychiatric manifestations. Urine analysis indicates aminoaciduria. Considering the presentation and the urinary findings, this disorder is likely due to a mutation in which of the following genes?",
      "options": [
        {
          "label": "A",
          "text": "SLC5A18",
          "correct": false
        },
        {
          "label": "B",
          "text": "SLC1A1",
          "correct": false
        },
        {
          "label": "C",
          "text": "SLC7A9",
          "correct": false
        },
        {
          "label": "D",
          "text": "SLC6A19",
          "correct": true
        }
      ],
      "correct_answer": "D. SLC6A19",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. D.</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation</li><li>\u2022 :</li><li>\u2022 Option A. SLC5A18: This gene is not associated with the described clinical presentation or aminoaciduria related to Hartnup disease.</li><li>\u2022 Option</li><li>\u2022 A. SLC5A18:</li><li>\u2022 not associated</li><li>\u2022 Option B. SLC1A1: While this gene is involved in amino acid transport, mutations in SLC1A1 are not typically linked to the symptoms described here.</li><li>\u2022 Option</li><li>\u2022 B. SLC1A1:</li><li>\u2022 amino acid transport,</li><li>\u2022 Option C. SLC7A9: Mutations in this gene are associated with cystinuria, a different condition characterized by defective renal reabsorption of certain amino acids, leading to kidney stone formation, not the symptoms described.</li><li>\u2022 Option</li><li>\u2022 C. SLC7A9:</li><li>\u2022 Mutations</li><li>\u2022 cystinuria,</li></ul>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective:</li><li>\u27a4 P ellagra-like symptoms (dermatitis, diarrhea, dementia), along with aminoaciduria , suggests Hartnup disease , which is characterized by the defective absorption of neutral amino acids, including tryptophan. Hartnup disease is caused by mutations in the SLC6A19 gene, which encodes a transporter protein responsible for the absorption of neutral amino acids in the intestines and kidneys.</li><li>\u27a4 P</li><li>\u27a4 ellagra-like symptoms</li><li>\u27a4 aminoaciduria</li><li>\u27a4 Hartnup disease</li><li>\u27a4 defective absorption of neutral amino acids,</li><li>\u27a4 tryptophan.</li><li>\u27a4 Ref : Harper 30/e:  p 308, 557</li><li>\u27a4 Ref</li><li>\u27a4 : Harper 30/e:  p 308, 557</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "abb9b01a",
      "audio": ""
    },
    {
      "text": "During a case discussion, involving altered immune and neurological functions, focusing on a specific metabolic pathway. The students are asked to identify the precursor amino acid in the kynurenine pathway, known to impact both neurological and immune responses. Which amino acid is focus of this discussion?",
      "options": [
        {
          "label": "A",
          "text": "Phenylalanine",
          "correct": false
        },
        {
          "label": "B",
          "text": "Tryptophan",
          "correct": true
        },
        {
          "label": "C",
          "text": "Tyrosine",
          "correct": false
        },
        {
          "label": "D",
          "text": "Histidine",
          "correct": false
        }
      ],
      "correct_answer": "B. Tryptophan",
      "question_images": [],
      "explanation_images": [
        "https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/04/04/picture21.jpg"
      ],
      "explanation": "<p><strong>Ans. B.</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation</li><li>\u2022 :</li><li>\u2022 Option A. Phenylalanine: This amino acid is primarily converted into tyrosine , not kynurenine.</li><li>\u2022 Option</li><li>\u2022 A. Phenylalanine:</li><li>\u2022 amino acid</li><li>\u2022 converted into tyrosine</li><li>\u2022 Option C. Tyrosine: Tyrosine is a precursor for several important substances, including dopamine, epinephrine , and norepinephrine, but not kynurenine.</li><li>\u2022 Option</li><li>\u2022 C. Tyrosine:</li><li>\u2022 substances,</li><li>\u2022 dopamine, epinephrine</li><li>\u2022 norepinephrine,</li><li>\u2022 Option D. Histidine: Histidine is metabolized into histamine, among other products, and does not lead to kynurenine formation.</li><li>\u2022 Option</li><li>\u2022 D. Histidine:</li><li>\u2022 metabolized into histamine,</li></ul>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective:</li><li>\u27a4 Kynurenine is formed from the catabolism of tryptophan via the kynurenine pathway . This pathway is crucial not only for the degradation of tryptophan but also for the production of several important metabolites, including nicotinamide adenine dinucleotide (NAD+), which plays a vital role in cellular energy metabolism and cellular signaling processes.</li><li>\u27a4 Kynurenine</li><li>\u27a4 formed from the catabolism</li><li>\u27a4 tryptophan</li><li>\u27a4 kynurenine pathway</li><li>\u27a4 pathway</li><li>\u27a4 degradation of tryptophan</li><li>\u27a4 production of several important metabolites,</li><li>\u27a4 nicotinamide adenine</li><li>\u27a4 dinucleotide</li><li>\u27a4 vital role in cellular energy metabolism</li><li>\u27a4 Ref : DM Vasudevan 9/e: p 240.</li><li>\u27a4 Ref</li><li>\u27a4 : DM Vasudevan 9/e: p 240.</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "6b9af3cf",
      "audio": ""
    },
    {
      "text": "During a clinical review session focusing on metabolic disorders, a discussion emerges about the diagnostic markers associated with specific amino acid metabolic pathways. A resident recalls a case where elevated levels of FIGLU were noted in a patient's laboratory results, suggesting a disruption in a particular amino acid's metabolism. Which amino acids metabolic pathway is most likely associated with FIGLU as an intermediate?",
      "options": [
        {
          "label": "A",
          "text": "Valine",
          "correct": false
        },
        {
          "label": "B",
          "text": "Histidine",
          "correct": true
        },
        {
          "label": "C",
          "text": "Methionine",
          "correct": false
        },
        {
          "label": "D",
          "text": "Arginine",
          "correct": false
        }
      ],
      "correct_answer": "B. Histidine",
      "question_images": [],
      "explanation_images": [
        "https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/04/04/picture31.jpg"
      ],
      "explanation": "<p><strong>Ans. B.</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation</li><li>\u2022 :</li><li>\u2022 Option A. Valine: Incorrect, as valine metabolism does not involve FIGLU as an intermediate .</li><li>\u2022 Option</li><li>\u2022 A. Valine:</li><li>\u2022 valine metabolism</li><li>\u2022 not</li><li>\u2022 FIGLU as an intermediate</li><li>\u2022 Option C. Methionine: Incorrect, methionine metabolism involves different intermediates and pathways, particularly those related to sulfur.</li><li>\u2022 Option</li><li>\u2022 C. Methionine:</li><li>\u2022 methionine metabolism</li><li>\u2022 different intermediates</li><li>\u2022 pathways,</li><li>\u2022 Option D. Arginine: Incorrect, arginine metabolism is primarily concerned with the urea cycle and does not involve FIGLU.</li><li>\u2022 Option</li><li>\u2022 D. Arginine:</li><li>\u2022 primarily concerned with the urea cycle</li></ul>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective:</li><li>\u27a4 Formiminoglutamic acid (FIGLU) is an intermediate in the metabolism of histidine . Its accumulation can be observed in conditions like folic acid deficiency, as folic acid is required for the conversion of FIGLU into another metabolite in the histidine degradation pathway.</li><li>\u27a4 Formiminoglutamic acid</li><li>\u27a4 intermediate in the metabolism of histidine</li><li>\u27a4 accumulation</li><li>\u27a4 observed in conditions</li><li>\u27a4 folic acid deficiency,</li><li>\u27a4 folic acid</li><li>\u27a4 required for the conversion of FIGLU</li><li>\u27a4 another metabolite</li><li>\u27a4 histidine degradation pathway.</li><li>\u27a4 Ref : DM Vasudevan 9/e: p 243.</li><li>\u27a4 Ref</li><li>\u27a4 : DM Vasudevan 9/e: p 243.</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "0461abaa",
      "audio": ""
    },
    {
      "text": "Identify which of the following enzymes are considered hemoproteins.",
      "options": [
        {
          "label": "A",
          "text": "Nitric oxide synthase",
          "correct": false
        },
        {
          "label": "B",
          "text": "Tryptophan pyrrolase",
          "correct": false
        },
        {
          "label": "C",
          "text": "Both a & b",
          "correct": true
        },
        {
          "label": "D",
          "text": "None",
          "correct": false
        }
      ],
      "correct_answer": "C. Both a & b",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. C.</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation</li><li>\u2022 :</li><li>\u2022 Option A. Nitric oxide synthase: Correct , as it is a hemoprotein involved in the synthesis of nitric oxide.</li><li>\u2022 Option</li><li>\u2022 A. Nitric oxide synthase:</li><li>\u2022 Correct</li><li>\u2022 Option B. Tryptophan pyrrolase: Also correct, as it is a hemoprotein participating in the metabolism of tryptophan.</li><li>\u2022 Option</li><li>\u2022 B. Tryptophan pyrrolase:</li><li>\u2022 correct,</li><li>\u2022 Option D. None: Incorrect, as both listed enzymes are hemoproteins.</li><li>\u2022 Option</li><li>\u2022 D. None:</li></ul>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective:</li><li>\u27a4 Heme is present in:</li><li>\u27a4 Hemoglobin Myoglobin Cytochromes Peroxidase Catalase Tryptophan pyrrolase Nitric oxide synthase</li><li>\u27a4 Hemoglobin</li><li>\u27a4 Myoglobin</li><li>\u27a4 Cytochromes</li><li>\u27a4 Peroxidase</li><li>\u27a4 Catalase</li><li>\u27a4 Tryptophan pyrrolase</li><li>\u27a4 Tryptophan pyrrolase</li><li>\u27a4 Nitric oxide synthase</li><li>\u27a4 Nitric oxide synthase</li><li>\u27a4 Ref : DM Vasudevan 9/e: p 270.</li><li>\u27a4 Ref</li><li>\u27a4 : DM Vasudevan 9/e: p 270.</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "495f8edf",
      "audio": ""
    },
    {
      "text": "A woman of reproductive age with phenylketonuria (PKU) delivers her first child. The father has no family history of PKU. At birth, the neonate presents with microcephaly and elevated blood phenylalanine levels. Considering the mother's medical history and the absence of PKU in the father's family, what is the most likely explanation for the neonate's symptoms?",
      "options": [
        {
          "label": "A",
          "text": "Father is a carrier of PKU",
          "correct": false
        },
        {
          "label": "B",
          "text": "Maternal translocation with unbalanced segregation in meiosis I",
          "correct": false
        },
        {
          "label": "C",
          "text": "Maternal translocation with unbalanced segregation in meiosis II",
          "correct": false
        },
        {
          "label": "D",
          "text": "Phenylalanine was not adequately restricted from the mother\u2019s diet during pregnancy",
          "correct": true
        }
      ],
      "correct_answer": "D. Phenylalanine was not adequately restricted from the mother\u2019s diet during pregnancy",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. D.</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation</li><li>\u2022 :</li><li>\u2022 Option A. Father is a carrier of PKU: Even if the father is a carrier of PKU allele (phenylalanine hydroxylase gene), the infant will not have any symptoms until 4-5 days after birth, also the maternal blood phenylalanine level should be in the normal range throughout the course of pregnancy.</li><li>\u2022 Option A. Father is a carrier of PKU:</li><li>\u2022 father is a carrier of PKU allele</li><li>\u2022 infant will not have any symptoms</li><li>\u2022 4-5 days after birth,</li><li>\u2022 Option B. Maternal translocation with unbalanced segregation in meiosis I and Option C. Maternal translocation with unbalanced segregation in meiosis II: Maternal translocation with unbalanced segregation in meiosis I and meiosis II will not have effect on phenylalanine levels but leads to trisomy.</li><li>\u2022 Option B. Maternal translocation with unbalanced segregation in meiosis I</li><li>\u2022 Option C. Maternal translocation with unbalanced segregation in meiosis II:</li><li>\u2022 Maternal translocation</li><li>\u2022 unbalanced segregation in meiosis I</li><li>\u2022 meiosis II</li><li>\u2022 not</li></ul>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective:</li><li>\u27a4 Maternal PKU syndrome, occurs when a mother with PKU does not adequately control her phenylalanine levels during pregnancy. Elevated phenylalanine in the maternal bloodstream can cross the placenta , affecting fetal development and leading to conditions such as microcephaly and elevated blood phenylalanine in the newborn , despite the child not inheriting PKU.</li><li>\u27a4 Maternal PKU syndrome,</li><li>\u27a4 mother with PKU</li><li>\u27a4 not adequately control her phenylalanine levels</li><li>\u27a4 pregnancy.</li><li>\u27a4 Elevated phenylalanine</li><li>\u27a4 maternal bloodstream</li><li>\u27a4 cross the placenta</li><li>\u27a4 fetal development</li><li>\u27a4 microcephaly</li><li>\u27a4 elevated blood phenylalanine</li><li>\u27a4 newborn</li><li>\u27a4 Ref : Harper 30/e:  p 304,306.</li><li>\u27a4 Ref : Harper 30/e:  p 304,306.</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "30bdb3ed",
      "audio": ""
    },
    {
      "text": "A 2-day-old infant is brought to the pediatric ward for newborn screening, as seen in the images provided. Regarding the screening test depicted in the pictures, which of the following statements is incorrect?",
      "options": [
        {
          "label": "A",
          "text": "TMS is the best screening test to detect the metabolic disorders",
          "correct": false
        },
        {
          "label": "B",
          "text": "TMS is less sensitive in screening for PKU than the bacterial inhibition tests",
          "correct": true
        },
        {
          "label": "C",
          "text": "Blood obtained by heel-prick or cord blood is applied to a filter-paper",
          "correct": false
        },
        {
          "label": "D",
          "text": "Has Capacity to screen multiple disorders with a single blood spot",
          "correct": false
        }
      ],
      "correct_answer": "B. TMS is less sensitive in screening for PKU than the bacterial inhibition tests",
      "question_images": [
        "https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/04/04/picture41.jpg"
      ],
      "explanation_images": [
        "https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/04/04/picture5_XIxp1ec.jpg"
      ],
      "explanation": "<p><strong>Ans. B. TMS is less sensitive in screening for PKU than the bacterial inhibition tests</strong></p>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective:</li><li>\u27a4 The sensitivity of tandem MS-MS testing in screening for PKU is greater than the sensitivity of any bacterial inhibition or biochemical method for measuring blood phenylalanine levels. The power of new-born screening by tandem MS-MS is enormously enhanced by the ability to analyze several metabolites simultaneously in the same blood specimen.</li><li>\u27a4 Ref : DM Vasudevan 9/e: p 427,458.</li><li>\u27a4 Ref</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "d54935e9",
      "audio": ""
    },
    {
      "text": "Assertion (A): Cheesy odor in urine is mainly due to isovaleric acid excretion in urine, which is one of the intermediates formed during catabolism of leucine. Reasoning (R): The defective enzyme in isovaleric acidemia is isovaleryl CoA dehydrogenase which is a FAD + dependent enzyme. Which of the following is correct regarding the Assertion (A) and Reasoning (R)?",
      "options": [
        {
          "label": "A",
          "text": "A and R both are wrong",
          "correct": false
        },
        {
          "label": "B",
          "text": "A is a wrong but R is a right statement",
          "correct": false
        },
        {
          "label": "C",
          "text": "A and R both are right but R is not the correct explanation of A",
          "correct": false
        },
        {
          "label": "D",
          "text": "A as well as R are right and R is a correct explanation of A",
          "correct": true
        }
      ],
      "correct_answer": "D. A as well as R are right and R is a correct explanation of A",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. D.</strong></p>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective:</li><li>\u27a4 Isovaleric acidemia (FAD+ dependent enzyme) is a metabolic disorder characterized by the accumulation and excretion of isovaleric acid in the urine , which leads to the distinctive \"cheesy\" odor. This condition is due to a deficiency in isovaleryl CoA dehydrogenase, an enzyme crucial for the catabolism of leucine, an essential amino acid.</li><li>\u27a4 Isovaleric acidemia</li><li>\u27a4 metabolic disorder</li><li>\u27a4 accumulation</li><li>\u27a4 excretion of isovaleric acid in the urine</li><li>\u27a4 distinctive \"cheesy\" odor.</li><li>\u27a4 Ref : Harper 30/e: p 309-312.</li><li>\u27a4 Ref : Harper 30/e: p 309-312.</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "681f35a9",
      "audio": ""
    },
    {
      "text": "A 45-year-old male with severe back pain and difficulty in walking is observed to have a bluish-black discoloration of the ear cartilage and darkening of the urine upon standing. Which enzyme deficiency is most likely responsible for his condition?",
      "options": [
        {
          "label": "A",
          "text": "Tyrosine Hydroxylase",
          "correct": false
        },
        {
          "label": "B",
          "text": "Homogentisate Oxidase",
          "correct": true
        },
        {
          "label": "C",
          "text": "Tyrosine Transaminase",
          "correct": false
        },
        {
          "label": "D",
          "text": "Tyrosinase",
          "correct": false
        }
      ],
      "correct_answer": "B. Homogentisate Oxidase",
      "question_images": [
        "https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/04/04/picture6_08b8XZK.jpg"
      ],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. B.</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation</li><li>\u2022 :</li><li>\u2022 Option A. Tyrosine Hydroxylase: Tyrosine is hydroxylated to dihydroxyphenylalanine (DOPA) by tyrosine hydroxylase, which requires BH4 and NADPH. Tyrosine hydroxylase is present in adrenal medulla and the DOPA thus generated is used for catecholamine synthesis.</li><li>\u2022 Option A. Tyrosine Hydroxylase:</li><li>\u2022 Tyrosine</li><li>\u2022 hydroxylated to dihydroxyphenylalanine</li><li>\u2022 tyrosine hydroxylase,</li><li>\u2022 requires BH4 and NADPH.</li><li>\u2022 Option C. Tyrosine Transaminase: Deficiency leads to Oculocutaneous Tyrosinemia (Tyrosinemia Type II), C/F - Mental retardation, keratosis of palmar surface, painful corneal lesions and photophobia with increased excretion of tyrosine and tyramine in urine. A diet low in protein is advised.</li><li>\u2022 Option C. Tyrosine Transaminase:</li><li>\u2022 Oculocutaneous Tyrosinemia</li><li>\u2022 C/F</li><li>\u2022 Option D. Tyrosinase: It is completely absent \u2192 defective synthesis of melanin \u2192 AR disease , Albinism . C/F - skin has low pigmentation \u2192sensitive to UV rays \u2192nevi and melanomas, white hair, ocular fundus is hypopigmented and iris may be gray or red, photophobia, nystagmus and decreased visual acuity.</li><li>\u2022 Option D. Tyrosinase:</li><li>\u2022 completely absent</li><li>\u2022 defective synthesis of melanin</li><li>\u2022 AR disease</li><li>\u2022 Albinism</li><li>\u2022 C/F</li></ul>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective:</li><li>\u27a4 Alkaptonuria is characterized by the accumulation of homogentisic acid , a metabolic byproduct of phenylalanine and tyrosine catabolism . This accumulation is due to a deficiency in the enzyme homogentisate oxidase. The hallmark features of this condition include darkening of the urine upon standing (due to the oxidation of homogentisic acid), ochronosis (bluish-black discoloration of connective tissues), and arthropathies (joint diseases), particularly affecting the spine and large joints.</li><li>\u27a4 Alkaptonuria</li><li>\u27a4 accumulation of homogentisic acid</li><li>\u27a4 metabolic byproduct of phenylalanine</li><li>\u27a4 tyrosine catabolism</li><li>\u27a4 accumulation</li><li>\u27a4 deficiency in the enzyme homogentisate oxidase.</li><li>\u27a4 Ref : Harper 30/e: p 304-305.</li><li>\u27a4 Ref</li><li>\u27a4 : Harper 30/e: p 304-305.</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "b6f6ce05",
      "audio": ""
    },
    {
      "text": "A 62-year-old male presents with intermittent involuntary tremors in his left hand, difficulty feeding himself, walking challenges, and poor gait coordination for the past month. Upon examination, he exhibits a shuffling gait and resting tremors, but cognitive functions remain intact. Diagnosed with Parkinson's disease, he is prescribed levodopa. Which metabolic pathway is primarily affected in this condition?",
      "options": [
        {
          "label": "A",
          "text": "Phenylalanine",
          "correct": false
        },
        {
          "label": "B",
          "text": "Tryptophan",
          "correct": false
        },
        {
          "label": "C",
          "text": "Tyrosine",
          "correct": true
        },
        {
          "label": "D",
          "text": "Histidine",
          "correct": false
        }
      ],
      "correct_answer": "C. Tyrosine",
      "question_images": [],
      "explanation_images": [
        "https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/04/04/picture8_lTZg06l.jpg"
      ],
      "explanation": "<p><strong>Ans. C.</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation</li><li>\u2022 :</li><li>\u2022 Option A. Phenylalanine: While phenylalanine is a precursor to tyrosine , the direct pathway affected in Parkinson's disease is the tyrosine to dopamine pathway.</li><li>\u2022 Option</li><li>\u2022 A. Phenylalanine:</li><li>\u2022 precursor to tyrosine</li><li>\u2022 Option B. Tryptophan: Involved in the synthesis of serotonin and melatonin , not directly implicated in Parkinson's disease.</li><li>\u2022 Option</li><li>\u2022 B. Tryptophan:</li><li>\u2022 synthesis of serotonin and melatonin</li><li>\u2022 Option D. Histidine: Involved in the synthesis of histamine and is not directly related to the dopaminergic pathways affected in Parkinson's disease.</li><li>\u2022 Option</li><li>\u2022 D. Histidine:</li><li>\u2022 synthesis of histamine</li></ul>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective:</li><li>\u27a4 Parkinson's disease is associated with the dopaminergic pathway , where tyrosine is a key precursor in the synthesis of dopamine. Levodopa , a precursor of dopamine , is used to increase dopamine levels in the brain, addressing the dopamine deficiency that characterizes Parkinson's disease.</li><li>\u27a4 Parkinson's disease</li><li>\u27a4 dopaminergic pathway</li><li>\u27a4 tyrosine</li><li>\u27a4 key precursor</li><li>\u27a4 synthesis of dopamine.</li><li>\u27a4 Levodopa</li><li>\u27a4 precursor of dopamine</li><li>\u27a4 increase dopamine levels</li><li>\u27a4 brain,</li><li>\u27a4 Parkinson's disease.</li><li>\u27a4 Ref : DM Vasudevan 9/e: p 235.</li><li>\u27a4 Ref</li><li>\u27a4 : DM Vasudevan 9/e: p 235.</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "94095233",
      "audio": ""
    },
    {
      "text": "A 3-year-old male child presents with a 5-month history of eye ulceration and thick, rough, patchy skin on the palms and feet. Examination reveals dendritic corneal ulceration unresponsive to antiviral treatment and keratosis on the palms and plantar surfaces. Laboratory tests show increased levels of tyrosine in blood and urine. What is the most likely diagnosis?",
      "options": [
        {
          "label": "A",
          "text": "Tyrosinemia type-2",
          "correct": true
        },
        {
          "label": "B",
          "text": "Tyrosinemia type-1",
          "correct": false
        },
        {
          "label": "C",
          "text": "Tyrosinemia type-3",
          "correct": false
        },
        {
          "label": "D",
          "text": "Hawkinsinuria",
          "correct": false
        }
      ],
      "correct_answer": "A. Tyrosinemia type-2",
      "question_images": [
        "https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/04/04/picture9.jpg"
      ],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. A.</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation</li><li>\u2022 :</li><li>\u2022 Option B. Hepatorenal Tyrosinemia (Tyrosinemia Type I) is due to a deficiency of enzyme fumarylacetoacetate hydrolase . C/F: mild mental retardation, Cabbage like odour in urine, hypoglycemia liver failure and finally death occurs</li><li>\u2022 Option B. Hepatorenal Tyrosinemia (Tyrosinemia Type I)</li><li>\u2022 deficiency of enzyme fumarylacetoacetate hydrolase</li><li>\u2022 Option C. Neonatal Tyrosinemia (Tyrosinemia Type III) due to the absence of the enzyme para-hydroxyphenylpyruvate hydroxylase , which causes transient hypertyrosinemia in the newborn , and this will respond to ascorbic acid and dietary protein restriction.</li><li>\u2022 Option C. Neonatal Tyrosinemia (Tyrosinemia Type III)</li><li>\u2022 absence</li><li>\u2022 enzyme para-hydroxyphenylpyruvate hydroxylase</li><li>\u2022 transient hypertyrosinemia</li><li>\u2022 newborn</li><li>\u2022 Option D. Hawkinsinuria is due to dysfunction of p-HPPA oxidase, characterized by excretion of hawkinsin in urine , a derivative of p-HPPA.</li><li>\u2022 Option D.</li><li>\u2022 Hawkinsinuria</li><li>\u2022 dysfunction of p-HPPA oxidase,</li><li>\u2022 excretion of hawkinsin in urine</li></ul>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective:</li><li>\u27a4 Tyrosinemia type-2, also known as Richner-Hanhart syndrome, is characterized by elevated levels of tyrosine which can lead to eye problems (like corneal ulcers), skin disorders (such as palmoplantar keratosis), and sometimes intellectual disability.</li><li>\u27a4 Tyrosinemia type-2,</li><li>\u27a4 Richner-Hanhart syndrome,</li><li>\u27a4 elevated levels of tyrosine</li><li>\u27a4 lead to eye problems</li><li>\u27a4 skin disorders</li><li>\u27a4 intellectual disability.</li><li>\u27a4 Ref : DM Vasudevan 9/e: p 239.</li><li>\u27a4 Ref</li><li>\u27a4 : DM Vasudevan 9/e: p 239.</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "79141b91",
      "audio": ""
    },
    {
      "text": "Creatinine is synthesized in the body through a process involving the breakdown of a specific amino acid. Which amino acid is primarily involved in the formation of creatinine?",
      "options": [
        {
          "label": "A",
          "text": "Arginine",
          "correct": true
        },
        {
          "label": "B",
          "text": "Lysine",
          "correct": false
        },
        {
          "label": "C",
          "text": "Histamine",
          "correct": false
        },
        {
          "label": "D",
          "text": "Leucine",
          "correct": false
        }
      ],
      "correct_answer": "A. Arginine",
      "question_images": [],
      "explanation_images": [
        "https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/04/04/picture111.jpg"
      ],
      "explanation": "<p><strong>Ans. A.</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation</li><li>\u2022 :</li><li>\u2022 Option B. Lysine: While lysine is involved in many biochemical processes , it is not directly involved in the synthesis of creatinine.</li><li>\u2022 Option</li><li>\u2022 B. Lysine:</li><li>\u2022 many biochemical processes</li><li>\u2022 Option C. Histamine: Histamine is a biogenic amine derived from histidine and is not involved in creatinine synthesis.</li><li>\u2022 Option</li><li>\u2022 C. Histamine:</li><li>\u2022 biogenic amine</li><li>\u2022 Option D. Leucine: Leucine is a branched-chain amino acid involved in protein synthesis and energy production but not in the formation of creatinine.</li><li>\u2022 Option</li><li>\u2022 D. Leucine:</li><li>\u2022 branched-chain amino acid</li><li>\u2022 protein synthesis</li><li>\u2022 energy production</li></ul>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective:</li><li>\u27a4 Creatinine is formed from the breakdown of creatine phosphate in muscle and to a smaller extent from the diet. Creatine itself is synthesized from the amino acids arginine , glycine, and methionine . Arginine plays a crucial role in the initial step of creatine synthesis, which ultimately leads to the formation of creatinine.</li><li>\u27a4 Creatinine</li><li>\u27a4 breakdown of creatine phosphate in muscle</li><li>\u27a4 smaller extent from the diet.</li><li>\u27a4 Creatine</li><li>\u27a4 synthesized from the amino acids arginine</li><li>\u27a4 glycine,</li><li>\u27a4 methionine</li><li>\u27a4 Ref : Harper 30/e p320.</li><li>\u27a4 Ref</li><li>\u27a4 : Harper 30/e p320.</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "b3cf53d0",
      "audio": ""
    },
    {
      "text": "Polyamines are organic compounds that play a critical role in cellular processes. Which of the following is an example of a polyamine?",
      "options": [
        {
          "label": "A",
          "text": "Spermidine",
          "correct": true
        },
        {
          "label": "B",
          "text": "Arginine",
          "correct": false
        },
        {
          "label": "C",
          "text": "Histamine",
          "correct": false
        },
        {
          "label": "D",
          "text": "Lysine",
          "correct": false
        }
      ],
      "correct_answer": "A. Spermidine",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. A.</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation</li><li>\u2022 :</li><li>\u2022 Option B. Arginine: An amino acid, not a polyamine, although it is involved in the synthesis of polyamines.</li><li>\u2022 Option</li><li>\u2022 B. Arginine:</li><li>\u2022 amino acid,</li><li>\u2022 Option C. Histamine: A biogenic amine derived from histidine , involved in immune responses and not classified as a polyamine.</li><li>\u2022 Option</li><li>\u2022 C. Histamine:</li><li>\u2022 biogenic amine</li><li>\u2022 histidine</li><li>\u2022 immune responses</li><li>\u2022 Option D. Lysine: An essential amino acid important for protein synthesis, not a polyamine.</li><li>\u2022 Option</li><li>\u2022 D. Lysine:</li><li>\u2022 essential amino acid</li><li>\u2022 protein synthesis,</li></ul>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective:</li><li>\u27a4 Spermidine is a polyamine involved in cellular metabolism and is found in ribosomes and living tissues . It plays a role in cellular growth, proliferation, and differentiation.</li><li>\u27a4 Spermidine</li><li>\u27a4 polyamine</li><li>\u27a4 cellular metabolism</li><li>\u27a4 found in ribosomes and living tissues</li><li>\u27a4 cellular growth, proliferation, and differentiation.</li><li>\u27a4 Ref : DM Vasudevan 9/e: p 229.</li><li>\u27a4 Ref</li><li>\u27a4 : DM Vasudevan 9/e: p 229.</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "83e15225",
      "audio": ""
    },
    {
      "text": "Following routine newborn screening, a child is found to have high levels of phenylpyruvate and phenylacetate, indicative of phenylketonuria (PKU). Despite a phenylalanine-restricted diet, the child shows developmental delays. Which supplement might improve the child's condition?",
      "options": [
        {
          "label": "A",
          "text": "Tyrosine",
          "correct": true
        },
        {
          "label": "B",
          "text": "5-hydroxytryptophan",
          "correct": false
        },
        {
          "label": "C",
          "text": "Melanin",
          "correct": false
        },
        {
          "label": "D",
          "text": "Phenylalanine",
          "correct": false
        }
      ],
      "correct_answer": "A. Tyrosine",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. A. Tyrosine</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation:</li><li>\u2022 Phenylketonuria (PKU) results from a deficiency of phenylalanine hydroxylase (PAH), the enzyme that converts phenylalanine to tyrosine. This deficiency leads to:</li><li>\u2022 Accumulation of phenylalanine and its metabolites (phenylpyruvate, phenylacetate, phenyllactate) Reduced tyrosine production, making tyrosine an essential amino acid in PKU patients</li><li>\u2022 Accumulation of phenylalanine and its metabolites (phenylpyruvate, phenylacetate, phenyllactate)</li><li>\u2022 Reduced tyrosine production, making tyrosine an essential amino acid in PKU patients</li><li>\u2022 In PKU treatment, dietary phenylalanine restriction is the primary approach to prevent neurotoxicity from excess phenylalanine. However, this restriction alone can lead to tyrosine deficiency, as tyrosine can no longer be synthesized from phenylalanine.</li><li>\u2022 Tyrosine is critical for:</li><li>\u2022 Production of neurotransmitters (dopamine, norepinephrine, epinephrine) Synthesis of thyroid hormones Melanin production</li><li>\u2022 Production of neurotransmitters (dopamine, norepinephrine, epinephrine)</li><li>\u2022 Synthesis of thyroid hormones</li><li>\u2022 Melanin production</li><li>\u2022 Tyrosine supplementation is therefore beneficial in PKU management as it:</li><li>\u2022 Addresses the conditionally essential status of tyrosine Supports neurotransmitter synthesis, potentially improving neurological function May reduce the risk of developmental delays associated with tyrosine deficiency</li><li>\u2022 Addresses the conditionally essential status of tyrosine</li><li>\u2022 Supports neurotransmitter synthesis, potentially improving neurological function</li><li>\u2022 May reduce the risk of developmental delays associated with tyrosine deficiency</li><li>\u2022 Other Options:</li><li>\u2022 Other Options:</li><li>\u2022 Option B. 5-hydroxytryptophan : This is a precursor to serotonin in the tryptophan metabolism pathway. While serotonin levels might be indirectly affected in PKU due to competition between elevated phenylalanine and tryptophan for transport across the blood-brain barrier, supplementing with 5-hydroxytryptophan does not address the primary biochemical defect or the tyrosine deficiency in PKU.</li><li>\u2022 Option B. 5-hydroxytryptophan</li><li>\u2022 Option C. Melanin : This is an end product of tyrosine metabolism and not a supplement that would provide therapeutic benefit in PKU. The hypopigmentation sometimes seen in PKU patients is due to reduced tyrosine availability for melanin synthesis, but direct melanin supplementation would not address the metabolic or neurological issues.</li><li>\u2022 Option C. Melanin</li><li>\u2022 Option D. Phenylalanine : Supplementing with phenylalanine would be contraindicated in PKU as it would exacerbate the condition. PKU patients already have elevated phenylalanine levels due to impaired metabolism, and additional phenylalanine would increase toxic metabolite production and neurological damage.</li><li>\u2022 Option D. Phenylalanine</li></ul>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective:</li><li>\u27a4 In phenylketonuria, phenylalanine hydroxylase deficiency creates a metabolic block in converting phenylalanine to tyrosine. While dietary phenylalanine restriction is the mainstay of treatment, supplementation with tyrosine is important because it becomes an essential amino acid in this condition. Tyrosine supplementation supports neurotransmitter synthesis, and potentially improves developmental outcomes by addressing the \"downstream\" deficiency caused by the enzymatic block.</li><li>\u27a4 Ref : DM Vasudevan 9/e: p 236.</li><li>\u27a4 Ref</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "2008947f",
      "audio": ""
    },
    {
      "text": "A 5-year-old child with developmental delay undergoes blood analysis, which reveals elevated levels of phenylalanine, phenyllactate, and phenylpyruvate. What is the hypothesized mechanism for developmental delay in this condition?",
      "options": [
        {
          "label": "A",
          "text": "Acidosis due to elevated phenyllactate",
          "correct": false
        },
        {
          "label": "B",
          "text": "Lack of tyrosine, now an essential amino acid",
          "correct": false
        },
        {
          "label": "C",
          "text": "Inhibition of hydroxylating enzymes due to accumulation of phenylalanine",
          "correct": false
        },
        {
          "label": "D",
          "text": "Lack of large, neutral amino acids in the brain.",
          "correct": true
        }
      ],
      "correct_answer": "D. Lack of large, neutral amino acids in the brain.",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. D.</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation</li><li>\u2022 :</li><li>\u2022 Option A. Acidosis due to elevated phenyllactate: While acidosis can have deleterious effects on the body and can be a feature of organic acidemias , it is not the primary reason for developmental delays in conditions like phenylketonuria. Acidosis is more of an acute metabolic disturbance rather than a direct cause of chronic developmental issues.</li><li>\u2022 Option</li><li>\u2022 A. Acidosis due to elevated phenyllactate:</li><li>\u2022 acidosis</li><li>\u2022 deleterious effects</li><li>\u2022 body</li><li>\u2022 feature of organic acidemias</li><li>\u2022 Option B. Lack of tyrosine, now an essential amino acid: Tyrosine is a precursor for several neurotransmitters , and while its deficiency due to a block in conversion from phenylalanine can impact brain function , the developmental delay is more directly linked to the broader competition of phenylalanine with other LNAAs, rather than tyrosine deficiency alone.</li><li>\u2022 Option</li><li>\u2022 B. Lack of tyrosine, now an essential amino acid: Tyrosine</li><li>\u2022 precursor for several neurotransmitters</li><li>\u2022 deficiency</li><li>\u2022 block in conversion from phenylalanine</li><li>\u2022 impact brain function</li><li>\u2022 Option C. Inhibition of hydroxylating enzymes due to accumulation of phenylalanine: Phenylalanine can indeed inhibit certain enzymes , including hydroxylating enzymes , due to its elevated levels . This can have various metabolic effects, but the specific link to developmental delay is less direct compared to the competition of phenylalanine with other LNAAs for transport into the brain.</li><li>\u2022 Option</li><li>\u2022 C. Inhibition of hydroxylating enzymes due to accumulation of phenylalanine:</li><li>\u2022 Phenylalanine</li><li>\u2022 inhibit certain enzymes</li><li>\u2022 hydroxylating enzymes</li><li>\u2022 elevated levels</li></ul>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective:</li><li>\u27a4 Elevated levels of phenylalanine are known to interfere with the transport of other large , neutral amino acids (LNAAs) across the blood-brain barrier due to competitive inhibition . These LNAAs include tyrosine, tryptophan, and others that are precursors for key neurotransmitters essential for brain development and function. A deficiency in these neurotransmitters can result in developmental delays.</li><li>\u27a4 Elevated levels</li><li>\u27a4 phenylalanine</li><li>\u27a4 interfere with the transport of other large</li><li>\u27a4 neutral amino acids</li><li>\u27a4 blood-brain barrier</li><li>\u27a4 competitive inhibition</li><li>\u27a4 Ref :  DM Vasudevan 9/e: p 236.</li><li>\u27a4 Ref</li><li>\u27a4 :  DM Vasudevan 9/e: p 236.</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "747a3ced",
      "audio": ""
    },
    {
      "text": "A patient experiences episodes of flushing, diarrhea, abdominal cramping, and wheezing. Vital signs show normal blood pressure and pulse rate, but scattered telangiectasias are present. What is the most appropriate 24-hour urine test for diagnosis?",
      "options": [
        {
          "label": "A",
          "text": "Vanillylmandelic acid (VMAs)",
          "correct": false
        },
        {
          "label": "B",
          "text": "Dopamine",
          "correct": false
        },
        {
          "label": "C",
          "text": "5-hydroxyindoleacetic acid (5-HIAA)",
          "correct": true
        },
        {
          "label": "D",
          "text": "Cortisol",
          "correct": false
        }
      ],
      "correct_answer": "C. 5-hydroxyindoleacetic acid (5-HIAA)",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. C.</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation</li><li>\u2022 :</li><li>\u2022 Option A. Vanillylmandelic acid (VMAs): This is a breakdown product of norepinephrine and epinephrine and is often tested for in the context of suspected pheochromocytoma, which presents with different symptoms like episodic hypertension, palpitations, and headaches.</li><li>\u2022 Option</li><li>\u2022 A. Vanillylmandelic acid (VMAs):</li><li>\u2022 breakdown product of norepinephrine</li><li>\u2022 epinephrine</li><li>\u2022 Option B. Dopamine: Elevated levels of dopamine in urine could indicate a neuroendocrine tumor , like a pheochromocytoma, but this patient's symptoms align more closely with carcinoid syndrome.</li><li>\u2022 Option</li><li>\u2022 B. Dopamine:</li><li>\u2022 Elevated levels of dopamine</li><li>\u2022 urine</li><li>\u2022 neuroendocrine tumor</li><li>\u2022 pheochromocytoma,</li><li>\u2022 Option D. Cortisol: While cortisol can be measured in urine to test for Cushing's syndrome, the symptoms here are not typical of Cushing's syndrome, which usually includes features such as weight gain, fat distribution changes, and sometimes hypertension.</li><li>\u2022 Option</li><li>\u2022 D. Cortisol:</li><li>\u2022 measured in urine to test for Cushing's syndrome,</li></ul>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective:</li><li>\u27a4 24-hour urinary excretion of 5-HIAA is a useful diagnostic test for carcinoid syndrome.</li><li>\u27a4 24-hour urinary excretion</li><li>\u27a4 carcinoid syndrome.</li><li>\u27a4 Ref :  DM Vasudevan 9/e: p 241.</li><li>\u27a4 Ref</li><li>\u27a4 :  DM Vasudevan 9/e: p 241.</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "f717a6c3",
      "audio": ""
    },
    {
      "text": "A 32-year-old male has been prescribed an antidepressant that works by maintaining elevated levels of a specific neurotransmitter. This neurotransmitter is derived from which amino acid?",
      "options": [
        {
          "label": "A",
          "text": "Tryptophan",
          "correct": true
        },
        {
          "label": "B",
          "text": "Glutamate",
          "correct": false
        },
        {
          "label": "C",
          "text": "Histidine",
          "correct": false
        },
        {
          "label": "D",
          "text": "Glycine",
          "correct": false
        }
      ],
      "correct_answer": "A. Tryptophan",
      "question_images": [],
      "explanation_images": [
        "https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/04/04/picture1110.jpg"
      ],
      "explanation": "<p><strong>Ans. A.</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation</li><li>\u2022 :</li><li>\u2022 Option B. Glutamate is the precursor of GABA.</li><li>\u2022 Option B. Glutamate</li><li>\u2022 precursor of GABA.</li><li>\u2022 Option C. Histidine is the precursor for histamine.</li><li>\u2022 Option C. Histidine</li><li>\u2022 precursor for histamine.</li><li>\u2022 Option D. Glycine itself acts as a neurotransmitter in the brain.</li><li>\u2022 Option D. Glycine</li><li>\u2022 neurotransmitter in the brain.</li></ul>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective:</li><li>\u27a4 Tryptophan is the amino acid precursor to serotonin, a neurotransmitter commonly targeted by many antidepressants . Medications such as selective serotonin reuptake inhibitors (SSRIs) increase the level of serotonin in the brain by preventing its reuptake into neurons, thereby treating depression.</li><li>\u27a4 Tryptophan</li><li>\u27a4 amino acid precursor</li><li>\u27a4 neurotransmitter</li><li>\u27a4 targeted by many antidepressants</li><li>\u27a4 Medications</li><li>\u27a4 selective serotonin reuptake inhibitors</li><li>\u27a4 increase</li><li>\u27a4 level of serotonin</li><li>\u27a4 brain</li><li>\u27a4 Ref :  DM Vasudevan 9/e: p 236.</li><li>\u27a4 Ref :  DM Vasudevan 9/e: p 236.</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "abb92557",
      "audio": ""
    },
    {
      "text": "A 3-month-old boy presents to the outpatient department with failure to thrive, poor appetite, hepatomegaly, yellow discoloration of the eyes, vomiting, diarrhea, and a distinct cabbage-like odor. What amino acid metabolism defect is this disorder most likely associated with?",
      "options": [
        {
          "label": "A",
          "text": "Alanine",
          "correct": false
        },
        {
          "label": "B",
          "text": "Tryptophan",
          "correct": false
        },
        {
          "label": "C",
          "text": "Tyrosine",
          "correct": true
        },
        {
          "label": "D",
          "text": "Histidine",
          "correct": false
        }
      ],
      "correct_answer": "C. Tyrosine",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. C.</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation</li><li>\u2022 :</li><li>\u2022 Option A. Alanine: While alanine is an amino acid, it is not commonly associated with the symptoms described or a distinct odor.</li><li>\u2022 Option</li><li>\u2022 A. Alanine:</li><li>\u2022 amino acid,</li><li>\u2022 Option B. Tryptophan: Abnormal tryptophan metabolism can lead to several conditions, but the distinct clinical picture including odor does not typically link to tryptophan metabolism defects.</li><li>\u2022 Option</li><li>\u2022 B. Tryptophan:</li><li>\u2022 Abnormal tryptophan metabolism</li><li>\u2022 several conditions,</li><li>\u2022 Option D. Histidine: Disturbances in histidine metabolism , such as histidinemia , do not typically present with the constellation of symptoms described in the question.</li><li>\u2022 Option</li><li>\u2022 D. Histidine: Disturbances</li><li>\u2022 histidine metabolism</li><li>\u2022 histidinemia</li></ul>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective:</li><li>\u27a4 The clinical features of tyrosinemia type I , includes failure to thrive, poor appetite, hepatomegaly, jaundice, vomiting, diarrhea, and a distinct odor resembling cabbage due to the accumulation of tyrosine metabolites.</li><li>\u27a4 tyrosinemia type I</li><li>\u27a4 failure to thrive, poor appetite, hepatomegaly, jaundice, vomiting, diarrhea,</li><li>\u27a4 distinct odor</li><li>\u27a4 cabbage</li><li>\u27a4 accumulation of tyrosine metabolites.</li><li>\u27a4 Ref :  DM Vasudevan 9/e: p 239.</li><li>\u27a4 Ref</li><li>\u27a4 :  DM Vasudevan 9/e: p 239.</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "970bbd7c",
      "audio": ""
    },
    {
      "text": "A child presenting with elevated levels of \u03b1-ketoacids of branched-chain amino acids (BCAAs) would likely benefit from supplementation with which vitamin?",
      "options": [
        {
          "label": "A",
          "text": "Niacin",
          "correct": false
        },
        {
          "label": "B",
          "text": "Riboflavin",
          "correct": false
        },
        {
          "label": "C",
          "text": "B 12",
          "correct": false
        },
        {
          "label": "D",
          "text": "Thiamine",
          "correct": true
        }
      ],
      "correct_answer": "D. Thiamine",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. D.</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation</li><li>\u2022 :</li><li>\u2022 Option A. Niacin: Not directly involved in the function of the BCKAD complex or the metabolism of branched-chain amino acids.</li><li>\u2022 Option</li><li>\u2022 A. Niacin:</li><li>\u2022 Not directly involved</li><li>\u2022 function of the BCKAD complex</li><li>\u2022 Option B. Riboflavin: While riboflavin is a precursor to FAD, a cofactor for many enzymes, the direct connection to BCKAD complex activity in the context of MSUD is less significant than that of thiamine.</li><li>\u2022 Option</li><li>\u2022 B. Riboflavin:</li><li>\u2022 precursor to FAD,</li><li>\u2022 cofactor for many enzymes,</li><li>\u2022 Option C. B12: Vitamin B12 is crucial for neurological health and the metabolism of certain amino acids , but it is not a cofactor for the BCKAD complex involved in MSUD.</li><li>\u2022 Option</li><li>\u2022 C. B12:</li><li>\u2022 neurological health</li><li>\u2022 metabolism of certain amino acids</li></ul>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective:</li><li>\u27a4 High levels of specific \u03b1-ketoacids indicate Maple Syrup Urine Disease (MSUD), stemming from a deficiency in an enzyme complex vital for breaking down certain amino acids . Thiamine supplementation can improve the enzyme's activity in some MSUD patients, potentially bettering clinical outcomes.</li><li>\u27a4 High levels of specific \u03b1-ketoacids</li><li>\u27a4 Maple Syrup Urine Disease</li><li>\u27a4 stemming</li><li>\u27a4 deficiency in an enzyme complex vital</li><li>\u27a4 breaking down certain amino acids</li><li>\u27a4 Ref :  DM Vasudevan 9/e: p 208, 230, 431.</li><li>\u27a4 Ref</li><li>\u27a4 :  DM Vasudevan 9/e: p 208, 230, 431.</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "cdc8ea30",
      "audio": ""
    },
    {
      "text": "A newborn screening reveals elevated levels of branched-chain amino acids and their \u03b1-ketoacid derivatives, along with lactic acidosis. Which enzyme is likely affected by this disorder?",
      "options": [
        {
          "label": "A",
          "text": "\u03b1-ketoglutarate dehydrogenase",
          "correct": true
        },
        {
          "label": "B",
          "text": "Isocitrate dehydrogenase",
          "correct": false
        },
        {
          "label": "C",
          "text": "Malate dehydrogenase",
          "correct": false
        },
        {
          "label": "D",
          "text": "Succinate dehydrogenase",
          "correct": false
        }
      ],
      "correct_answer": "A. \u03b1-ketoglutarate dehydrogenase",
      "question_images": [],
      "explanation_images": [
        "https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/04/04/picture20.jpg"
      ],
      "explanation": "<p><strong>Ans. A.</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation</li><li>\u2022 :</li><li>\u2022 Option B. Isocitrate dehydrogenase: While part of the Krebs cycle , this enzyme is less directly impacted by the conditions described in the scenario.</li><li>\u2022 Option</li><li>\u2022 B. Isocitrate dehydrogenase:</li><li>\u2022 part of the Krebs cycle</li><li>\u2022 less directly impacted</li><li>\u2022 Option C. Malate dehydrogenase: Also part of the Krebs cycle , but the scenario specifically suggests an issue more closely related to \u03b1-ketoglutarate dehydrogenase due to the link with branched-chain amino acid metabolism.</li><li>\u2022 Option</li><li>\u2022 C. Malate dehydrogenase:</li><li>\u2022 Krebs cycle</li><li>\u2022 Option D. Succinate dehydrogenase: This enzyme is part of both the Krebs cycle and the electron transport chain , but the described symptoms do not specifically implicate this enzyme.</li><li>\u2022 Option</li><li>\u2022 D. Succinate dehydrogenase:</li><li>\u2022 enzyme is part of both</li><li>\u2022 Krebs cycle</li><li>\u2022 electron transport chain</li></ul>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective:</li><li>\u27a4 Elevated branched-chain amino acids and their derivatives, along with lactic acidosis, suggest mitochondrial disruption, potentially due to Maple Syrup Urine Disease (MSUD), affecting the Krebs cycle. Excess NADH from MSUD inhibits key enzymes like \u03b1-ketoglutarate dehydrogenase, leading to lactic acidosis by diverting pyruvate to lactate.</li><li>\u27a4 Elevated branched-chain amino acids</li><li>\u27a4 lactic acidosis,</li><li>\u27a4 mitochondrial disruption,</li><li>\u27a4 Maple Syrup Urine Disease</li><li>\u27a4 Krebs cycle.</li><li>\u27a4 Ref :  DM Vasudevan 9/e: p 208, 230, 431.</li><li>\u27a4 Ref</li><li>\u27a4 :  DM Vasudevan 9/e: p 208, 230, 431.</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "10aa33ba",
      "audio": ""
    },
    {
      "text": "A 6-month-old boy presents with lethargy and vomiting. His blood tests show high ammonia levels, and there's a family history of a similar condition in a male relative. Considering these findings, which enzyme deficiency is most likely causing his symptoms?",
      "options": [
        {
          "label": "A",
          "text": "Carbamoyl-phosphate synthase I",
          "correct": false
        },
        {
          "label": "B",
          "text": "Ornithine transcarbamylase",
          "correct": true
        },
        {
          "label": "C",
          "text": "Argininosuccinate synthetase",
          "correct": false
        },
        {
          "label": "D",
          "text": "Arginase",
          "correct": false
        }
      ],
      "correct_answer": "B. Ornithine transcarbamylase",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. B.</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation</li><li>\u2022 :</li><li>\u2022 Option A. Carbamoyl-phosphate synthase I: Deficiency in this enzyme leads to a urea cycle disorder, but it is not specifically associated with hyperammonemia type 2.</li><li>\u2022 Option A. Carbamoyl-phosphate synthase I:</li><li>\u2022 Deficiency</li><li>\u2022 enzyme leads to a urea cycle disorder,</li><li>\u2022 Option C. Argininosuccinate synthetase: This enzyme deficiency leads to citrullinemia , another type of urea cycle disorder, but not hyperammonemia type 2.</li><li>\u2022 Option</li><li>\u2022 C. Argininosuccinate synthetase:</li><li>\u2022 enzyme deficiency leads to citrullinemia</li><li>\u2022 Option D. Arginase: Arginase deficiency results in argininemia, yet another distinct urea cycle disorder, which also does not correspond to hyperammonemia type 2.</li><li>\u2022 Option</li><li>\u2022 D. Arginase:</li><li>\u2022 Arginase deficiency</li><li>\u2022 argininemia,</li></ul>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective</li><li>\u27a4 :</li><li>\u27a4 Hyperammonemia type 2 is specifically associated with a deficiency in the enzyme ornithine transcarbamylase (OTC).</li><li>\u27a4 Hyperammonemia type 2</li><li>\u27a4 deficiency in the enzyme ornithine transcarbamylase</li><li>\u27a4 Ref : DM Vasudevan 9/e: p 206.</li><li>\u27a4 Ref</li><li>\u27a4 : DM Vasudevan 9/e: p 206.</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "4b1ec8e2",
      "audio": ""
    },
    {
      "text": "A patient on antidepressants experienced an increased heart rate and sweating after consuming red wine and aged cheese. These symptoms are due to an inability to degrade which substance?",
      "options": [
        {
          "label": "A",
          "text": "Tyrosine",
          "correct": false
        },
        {
          "label": "B",
          "text": "Tyramine",
          "correct": true
        },
        {
          "label": "C",
          "text": "Serotonin",
          "correct": false
        },
        {
          "label": "D",
          "text": "Glycine",
          "correct": false
        }
      ],
      "correct_answer": "B. Tyramine",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. B.</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation</li><li>\u2022 :</li><li>\u2022 Option A. Tyrosine: Tyrosine is a precursor to tyramine and various neurotransmitters but is not directly responsible for the described symptoms.</li><li>\u2022 Option</li><li>\u2022 A. Tyrosine:</li><li>\u2022 precursor to tyramine</li><li>\u2022 various neurotransmitters</li><li>\u2022 Option C. Serotonin: While serotonin syndrome can result from certain drug interactions, particularly with serotonergic agents , the specific trigger of aged cheese and red wine points more towards a tyramine interaction.</li><li>\u2022 Option</li><li>\u2022 C. Serotonin:</li><li>\u2022 result from certain drug interactions,</li><li>\u2022 serotonergic agents</li><li>\u2022 Option D. Glycine: Glycine is an inhibitory neurotransmitter in the central nervous system and is not related to the symptoms described in the context of dietary intake and antidepressants.</li><li>\u2022 Option</li><li>\u2022 D. Glycine:</li><li>\u2022 inhibitory neurotransmitter</li><li>\u2022 central nervous system</li></ul>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective:</li><li>\u27a4 A hypertensive crisis can occur from consuming tyramine-rich foods while on MAOIs, as these antidepressants inhibit the breakdown of tyramine , leading to symptoms like increased heart rate and sweating.</li><li>\u27a4 hypertensive crisis</li><li>\u27a4 consuming tyramine-rich foods</li><li>\u27a4 MAOIs,</li><li>\u27a4 antidepressants inhibit</li><li>\u27a4 breakdown of tyramine</li><li>\u27a4 increased heart rate and sweating.</li><li>\u27a4 Ref :  DM Vasudevan 9/e: p 236, 555.</li><li>\u27a4 Ref</li><li>\u27a4 :  DM Vasudevan 9/e: p 236, 555.</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "837fd450",
      "audio": ""
    },
    {
      "text": "In the transamination reaction depicted, involving oxaloacetate and glutamate, which of the following correctly identifies the products X and Y?",
      "options": [
        {
          "label": "A",
          "text": "Alanine, \u03b1-ketoglutarate",
          "correct": false
        },
        {
          "label": "B",
          "text": "Aspartate, \u03b1-ketoglutarate",
          "correct": true
        },
        {
          "label": "C",
          "text": "Glutamate, alanine",
          "correct": false
        },
        {
          "label": "D",
          "text": "Pyruvate, aspartate",
          "correct": false
        }
      ],
      "correct_answer": "B. Aspartate, \u03b1-ketoglutarate",
      "question_images": [
        "https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/04/04/picture30.jpg"
      ],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. B.</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation</li><li>\u2022 :</li><li>\u2022 Option A. Alanine, \u03b1 -ketoglutarate: Alanine is formed through transamination involving pyruvate and an amino acid, not oxaloacetate.</li><li>\u2022 Option</li><li>\u2022 A. Alanine,</li><li>\u2022 \u03b1</li><li>\u2022 -ketoglutarate:</li><li>\u2022 formed through transamination</li><li>\u2022 pyruvate</li><li>\u2022 Option C. Glutamate, alanine: This option is incorrect; while glutamate is a reactant in the reaction , alanine is not a product of the transamination with oxaloacetate.</li><li>\u2022 Option</li><li>\u2022 C. Glutamate, alanine:</li><li>\u2022 glutamate is a reactant in the reaction</li><li>\u2022 Option D. Pyruvate, aspartate: Pyruvate can be involved in transamination reactions, but it is not a product when oxaloacetate is the keto acid acceptor.</li><li>\u2022 Option</li><li>\u2022 D. Pyruvate, aspartate:</li><li>\u2022 transamination reactions,</li></ul>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective</li><li>\u27a4 :</li><li>\u27a4 The biochemical pathways involving transamination reactions, such as the conversion of oxaloacetate and glutamate into aspartate and \u03b1-ketoglutarate.</li><li>\u27a4 biochemical pathways</li><li>\u27a4 transamination reactions,</li><li>\u27a4 glutamate into aspartate</li><li>\u27a4 \u03b1-ketoglutarate.</li><li>\u27a4 Ref : DM Vasudevan 9/e: p 201.</li><li>\u27a4 Ref : DM Vasudevan 9/e: p 201.</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "dec693eb",
      "audio": ""
    },
    {
      "text": "A 14-year-old boy presents with CNS dysfunction including altered sensorium, convulsions, ascites, jaundice, and distinct tufted hair. Abdominal ultrasound reveals hepatomegaly, and laboratory tests show elevated ammonia and high argininosuccinate levels in the cerebrospinal fluid. Which enzyme deficiency is likely responsible for these findings?",
      "options": [
        {
          "label": "A",
          "text": "Argininosuccinate lyase",
          "correct": true
        },
        {
          "label": "B",
          "text": "Arginase",
          "correct": false
        },
        {
          "label": "C",
          "text": "Argininosuccinate synthetase",
          "correct": false
        },
        {
          "label": "D",
          "text": "Fumarase",
          "correct": false
        }
      ],
      "correct_answer": "A. Argininosuccinate lyase",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. A.</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation</li><li>\u2022 :</li><li>\u2022 Option B Arginase: Hyperargininemia - Arginine increased in blood and CSF . Instead of arginine, cysteine and lysine are lost in urine.</li><li>\u2022 Option B Arginase:</li><li>\u2022 Hyperargininemia</li><li>\u2022 Arginine increased in blood</li><li>\u2022 CSF</li><li>\u2022 Option C. Argininosuccinate synthetase: Citrullinemia - with high blood levels of synthetase ammonia and citrulline and Citrullinuria.</li><li>\u2022 Option C. Argininosuccinate synthetase:</li><li>\u2022 Citrullinemia</li><li>\u2022 high blood levels of synthetase ammonia</li><li>\u2022 citrulline</li><li>\u2022 Option D. Fumarase: Argininosuccinate is cleaved by argininosuccinate lyase (argininosuccinase) to arginine and fumarate . The enzyme is inhibited by fumarase.</li><li>\u2022 Option D. Fumarase:</li><li>\u2022 Argininosuccinate</li><li>\u2022 argininosuccinate lyase</li><li>\u2022 arginine and fumarate</li></ul>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective:</li><li>\u27a4 Argininosuccinate lyase deficiency is the cause of argininosuccinic aciduria , which is characterized by elevated levels of ammonia and argininosuccinate , leading to symptoms of CNS dysfunction and hepatomegaly .</li><li>\u27a4 Argininosuccinate lyase deficiency</li><li>\u27a4 argininosuccinic aciduria</li><li>\u27a4 elevated levels of ammonia</li><li>\u27a4 argininosuccinate</li><li>\u27a4 CNS dysfunction</li><li>\u27a4 hepatomegaly</li><li>\u27a4 Ref : Harper30/e: p 295, Vasudevan 9/e: P 205-206.</li><li>\u27a4 Ref : Harper30/e: p 295, Vasudevan 9/e: P 205-206.</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "62e95fd4",
      "audio": ""
    },
    {
      "text": "A 10-year-old child presents with episodic confusion, vomiting, and a history of protein-averse eating habits. Laboratory evaluations reveal elevated serum ammonia. Further genetic testing indicates a defect in the transport of a specific amino acid into the mitochondria. Which of the following deficiency corresponds with these clinical findings in the context of the hyperammonemia-hyperornithinemia-homocitrullinuria (HHH) syndrome?",
      "options": [
        {
          "label": "A",
          "text": "Ornithine transporter deficiency",
          "correct": true
        },
        {
          "label": "B",
          "text": "Carbamoyl-phosphate synthase I",
          "correct": false
        },
        {
          "label": "C",
          "text": "Ornithine transcarbamylase",
          "correct": false
        },
        {
          "label": "D",
          "text": "Argininosuccinate synthetase",
          "correct": false
        }
      ],
      "correct_answer": "A. Ornithine transporter deficiency",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. A. Ornithine transporter deficiency</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation</li><li>\u2022 Option B . Carbamoyl phosphate synthetase I deficiency causes Hyperammonemia type I.</li><li>\u2022 Option B</li><li>\u2022 Option C . Ornithine transcarbamylase deficiency causes Hyperammonemia Type II.</li><li>\u2022 Option C</li><li>\u2022 Option D . Argininosuccinate synthetase deficiency is characterized by hyperammonemia and citrullinemia with elevated CSF citrulline levels.</li><li>\u2022 Option D</li></ul>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective:</li><li>\u27a4 HHH syndrome is characterized by a triad of hyperammonemia, hyperornithinemia, and homocitrullinuria, which arises from a defect in the mitochondrial ornithine transporter.</li><li>\u27a4 Ref : DM Vasudevan 9/e: p 205.</li><li>\u27a4 Ref</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "b39367c7",
      "audio": ""
    },
    {
      "text": "A 4-year-old child presents with episodic irritability, vomiting, and brittle hair with peculiar 'trichorrhexis nodosa' on microscopy. Blood work reveals elevated plasma ammonia and argininosuccinic acid levels. The child has a known deficiency in a urea cycle enzyme. To bypass the enzymatic block and reduce hyperammonemia, which supplement should be added to the child\u2019s treatment regimen?",
      "options": [
        {
          "label": "A",
          "text": "\u200b\u200b\u200b\u200b\u200b Aspartate",
          "correct": false
        },
        {
          "label": "B",
          "text": "Arginine",
          "correct": true
        },
        {
          "label": "C",
          "text": "Citrulline",
          "correct": false
        },
        {
          "label": "D",
          "text": "Argininosuccinate",
          "correct": false
        }
      ],
      "correct_answer": "B. Arginine",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. B.</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation</li><li>\u2022 :</li><li>\u2022 Option A. Aspartate: While aspartate is a participant in the urea cycle , it is used earlier in the cycle and its supplementation does not bypass the block caused by argininosuccinase deficiency.</li><li>\u2022 Option</li><li>\u2022 A. Aspartate:</li><li>\u2022 participant in the urea cycle</li><li>\u2022 earlier in the cycle</li><li>\u2022 supplementation</li><li>\u2022 not bypass the block</li><li>\u2022 Option C. Citrulline: Citrulline is upstream of the block and would not be effective in bypassing the enzyme deficiency.</li><li>\u2022 Option</li><li>\u2022 C. Citrulline:</li><li>\u2022 upstream of the block</li><li>\u2022 Option D. Argininosuccinate: This is the substrate that accumulates due to the enzyme deficiency and its supplementation would not be helpful.</li><li>\u2022 Option</li><li>\u2022 D. Argininosuccinate:</li><li>\u2022 substrate that accumulates</li><li>\u2022 enzyme deficiency</li><li>\u2022 supplementation</li></ul>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective:</li><li>\u27a4 Argininosuccinic aciduria results from a deficiency in the enzyme argininosuccinase (argininosuccinate lyase), leading to an accumulation of argininosuccinic acid and hyperammonemia . Supplementation with arginine is beneficial as it provides an essential amino acid that is normally produced by the urea cycle and becomes essential in patients with this condition. This supplementation helps to continue the urea cycle, thus aiding in the detoxification of ammonia.</li><li>\u27a4 Argininosuccinic aciduria</li><li>\u27a4 deficiency in the enzyme argininosuccinase</li><li>\u27a4 accumulation of argininosuccinic acid</li><li>\u27a4 hyperammonemia</li><li>\u27a4 Supplementation</li><li>\u27a4 arginine</li><li>\u27a4 essential amino acid</li><li>\u27a4 normally produced by the urea cycle</li><li>\u27a4 Ref : DM Vasudevan 9/e: p 204.</li><li>\u27a4 Ref : DM Vasudevan 9/e: p 204.</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "9dfded5a",
      "audio": ""
    },
    {
      "text": "A newborn becomes lethargic and drowsy on day 24 post-birth. Laboratory tests reveal hyperammonemia and orotic aciduria. Which compound is this infant unable to directly synthesize due to an enzymatic deficiency?",
      "options": [
        {
          "label": "A",
          "text": "Carbamoyl phosphate",
          "correct": false
        },
        {
          "label": "B",
          "text": "Citrulline",
          "correct": true
        },
        {
          "label": "C",
          "text": "Argininosuccinate",
          "correct": false
        },
        {
          "label": "D",
          "text": "Arginine",
          "correct": false
        }
      ],
      "correct_answer": "B. Citrulline",
      "question_images": [],
      "explanation_images": [
        "https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/04/04/picture40.jpg"
      ],
      "explanation": "<p><strong>Ans. B.</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation</li><li>\u2022 :</li><li>\u2022 Option A. Carbamoyl phosphate: This compound is actually synthesized in excess in OTC deficiency because it cannot be properly utilized to form citrulline.</li><li>\u2022 Option</li><li>\u2022 A. Carbamoyl phosphate:</li><li>\u2022 compound</li><li>\u2022 synthesized in excess in OTC deficiency</li><li>\u2022 Option C. Argininosuccinate: The formation of argininosuccinate occurs after the synthesis of citrulline in the urea cycle , so while its production is also affected, the direct deficiency lies with the production of citrulline.</li><li>\u2022 Option</li><li>\u2022 C. Argininosuccinate:</li><li>\u2022 formation of argininosuccinate</li><li>\u2022 after the synthesis of citrulline</li><li>\u2022 urea cycle</li><li>\u2022 Option D. Arginine: Arginine is the final product of the urea cycle , and its synthesis is indeed affected by OTC deficiency, but the immediate block is at the formation of citrulline.</li><li>\u2022 Option</li><li>\u2022 D. Arginine:</li><li>\u2022 final product of the urea cycle</li></ul>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective:</li><li>\u27a4 Ornithine transcarbamylase (OTC) deficiency , is one of the urea cycle disorders . OTC is responsible for the synthesis of citrulline from carbamoyl phosphate and ornithine . When OTC is deficient , carbamoyl phosphate cannot be converted to citrulline and instead is diverted to the pyrimidine synthesis pathway, leading to orotic aciduria.</li><li>\u27a4 Ornithine transcarbamylase</li><li>\u27a4 deficiency</li><li>\u27a4 urea cycle disorders</li><li>\u27a4 OTC</li><li>\u27a4 synthesis of citrulline</li><li>\u27a4 carbamoyl phosphate</li><li>\u27a4 ornithine</li><li>\u27a4 OTC is deficient</li><li>\u27a4 carbamoyl phosphate cannot</li><li>\u27a4 converted to citrulline</li><li>\u27a4 diverted to the pyrimidine synthesis pathway,</li><li>\u27a4 orotic aciduria.</li><li>\u27a4 Ref : DM Vasudevan 9/e: p 205.</li><li>\u27a4 Ref : DM Vasudevan 9/e: p 205.</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "3bd504ef",
      "audio": ""
    },
    {
      "text": "A neonate is lethargic, drowsy, and irritable with blood analysis showing hyperammonemia and orotic aciduria. Considering this patient, orotic acid levels are high due to which of the following?",
      "options": [
        {
          "label": "A",
          "text": "Elevated ammonia",
          "correct": false
        },
        {
          "label": "B",
          "text": "Elevated glutamine",
          "correct": false
        },
        {
          "label": "C",
          "text": "Bypassing carbamoyl phosphate synthetase II (CPS-II)",
          "correct": true
        },
        {
          "label": "D",
          "text": "Bypassing aspartate transcarbamoylase",
          "correct": false
        }
      ],
      "correct_answer": "C. Bypassing carbamoyl phosphate synthetase II (CPS-II)",
      "question_images": [],
      "explanation_images": [
        "https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/04/04/picture50.jpg"
      ],
      "explanation": "<p><strong>Ans. C.</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation</li><li>\u2022 :</li><li>\u2022 Option A, Option B. The elevated ammonia is not a substrate of CPS-II and which glutamine is also elevated and is a substrate of CPS-II, higher glutamine concentrations will not overcome enzyme inhibition by its allosteric inhibitor, UTP.</li><li>\u2022 Option A, Option B.</li><li>\u2022 elevated ammonia</li><li>\u2022 not</li><li>\u2022 substrate of CPS-II</li><li>\u2022 glutamine is also elevated</li><li>\u2022 Option D. Aspartate transcarbamoylase is the regulated step of pyrimidine biosynthesis in many prokaryotic cells , but not in humans. This step is necessary for pyrimidines to be synthesized starting with carbamoyl phosphate.</li><li>\u2022 Option D.</li><li>\u2022 Aspartate transcarbamoylase</li><li>\u2022 regulated step of pyrimidine biosynthesis</li><li>\u2022 prokaryotic cells</li></ul>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective:</li><li>\u27a4 Hyperammonemia and orotic aciduria in a neonate suggest a urea cycle defect, particularly ornithine transcarbamylase deficiency , leading to the diversion of carbamoyl phosphate into the pyrimidine synthesis pathway and bypassing CPS-II.</li><li>\u27a4 Hyperammonemia</li><li>\u27a4 orotic aciduria</li><li>\u27a4 neonate</li><li>\u27a4 urea cycle defect,</li><li>\u27a4 ornithine transcarbamylase deficiency</li><li>\u27a4 diversion of carbamoyl phosphate</li><li>\u27a4 pyrimidine synthesis pathway</li><li>\u27a4 Ref : DM Vasudevan 9/e: p 205.</li><li>\u27a4 Ref : DM Vasudevan 9/e: p 205.</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "6dc5e6ab",
      "audio": ""
    },
    {
      "text": "A 7-year-old child with a diagnosed urea cycle disorder presents with recurrent episodes of hyperammonemia, especially after high-protein meals. Despite dietary protein restriction and ammonia scavenging medications, the child's ammonia levels remain intermittently elevated, leading to concerns about long-term neurological outcomes. The metabolic specialist considers augmenting the treatment regimen. Which combination of supplements could provide an alternative pathway for nitrogen excretion and help manage the child's condition more effectively?",
      "options": [
        {
          "label": "A",
          "text": "Arginine and glutamine",
          "correct": false
        },
        {
          "label": "B",
          "text": "Lysine and glutamine",
          "correct": false
        },
        {
          "label": "C",
          "text": "Arginine and benzoate",
          "correct": true
        },
        {
          "label": "D",
          "text": "Lysine and benzoate",
          "correct": false
        }
      ],
      "correct_answer": "C. Arginine and benzoate",
      "question_images": [],
      "explanation_images": [
        "https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/04/04/picture60.jpg"
      ],
      "explanation": "<p><strong>Ans. C.</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation</li><li>\u2022 :</li><li>\u2022 Option A. Arginine and glutamine: Glutamine is often elevated in UCDs as it binds with free ammonia ; however, supplementation with glutamine is not typically used for treatment because the body is already producing excess.</li><li>\u2022 Option</li><li>\u2022 A. Arginine and glutamine:</li><li>\u2022 Glutamine</li><li>\u2022 elevated in UCDs</li><li>\u2022 binds with free ammonia</li><li>\u2022 Option B. Lysine and glutamine: Lysine is not specifically involved in the urea cycle , and, as mentioned, glutamine is typically already elevated in UCDs.</li><li>\u2022 Option</li><li>\u2022 B. Lysine and glutamine:</li><li>\u2022 not</li><li>\u2022 involved in the urea cycle</li><li>\u2022 Option D. Lysine and benzoate: Lysine is not a supplement used in the management of UCDs , and while benzoate is used, it would not be paired with lysine for treatment.</li><li>\u2022 Option</li><li>\u2022 D. Lysine and benzoate:</li><li>\u2022 not</li><li>\u2022 supplement used in the management of UCDs</li></ul>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective:</li><li>\u27a4 Urea cycle disorders (UCDs) result in the body's inability to properly dispose of waste nitrogen from protein metabolism , leading to hyperammonemia. Arginine supplementation can be beneficial because it provides an essential amino acid that is often deficient in UCDs.</li><li>\u27a4 Urea cycle disorders</li><li>\u27a4 body's inability to properly dispose of waste nitrogen</li><li>\u27a4 protein metabolism</li><li>\u27a4 hyperammonemia.</li><li>\u27a4 Arginine supplementation</li><li>\u27a4 essential amino acid</li><li>\u27a4 Benzoate combines with glycine to form hippurate, which provides an alternative pathway for nitrogen excretion . This combination can help reduce ammonia levels in the blood by providing substrates for other nitrogen disposal pathways.</li><li>\u27a4 Benzoate</li><li>\u27a4 glycine to form hippurate,</li><li>\u27a4 alternative pathway for nitrogen excretion</li><li>\u27a4 Ref : DM Vasudevan 9/e: p 205</li><li>\u27a4 Ref : DM Vasudevan 9/e: p 205</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "57ae1da2",
      "audio": ""
    },
    {
      "text": "A 22-year-old male avid marathon runner presents to the clinic with fatigue and mild disorientation after long training sessions. Laboratory tests indicate slightly elevated ammonia levels. Given the patient's high level of physical activity, the physician considers the main route of ammonia transport from his skeletal muscles to the liver for detoxification. What is the primary form in which ammonia is transported in this scenario?",
      "options": [
        {
          "label": "A",
          "text": "Glutamine",
          "correct": false
        },
        {
          "label": "B",
          "text": "Alanine",
          "correct": true
        },
        {
          "label": "C",
          "text": "Both a and b",
          "correct": false
        },
        {
          "label": "D",
          "text": "None",
          "correct": false
        }
      ],
      "correct_answer": "B. Alanine",
      "question_images": [],
      "explanation_images": [
        "https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/04/04/picture70_0cAP8yW.jpg"
      ],
      "explanation": "<p><strong>Ans. B.</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation</li><li>\u2022 :</li><li>\u2022 Option A. Glutamine: While glutamine is a significant carrier of ammonia, particularly in the brain and other tissues , in the context of intense physical activity, alanine plays a more direct role in transporting ammonia from muscles due to its involvement in the alanine-glucose cycle.</li><li>\u2022 Option</li><li>\u2022 A. Glutamine:</li><li>\u2022 carrier of ammonia,</li><li>\u2022 brain and other tissues</li><li>\u2022 Option C. Both A and B: Although glutamine does play a role in ammonia transport , the primary form under conditions of intense physical activity, like marathon running, is alanine due to the rapid generation and need for detoxification of ammonia.</li><li>\u2022 Option</li><li>\u2022 C. Both A and B:</li><li>\u2022 glutamine</li><li>\u2022 role in ammonia transport</li></ul>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective:</li><li>\u27a4 During intense physical activity , alanine serves as the primary transporter of ammonia from skeletal muscle to the liver for detoxification , via the alanine-glucose cycle</li><li>\u27a4 intense physical activity</li><li>\u27a4 alanine</li><li>\u27a4 primary transporter of ammonia</li><li>\u27a4 skeletal muscle</li><li>\u27a4 liver for detoxification</li><li>\u27a4 Ref : DM Vasudevan 9/e: p 203.</li><li>\u27a4 Ref : DM Vasudevan 9/e: p 203.</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "1053d34e",
      "audio": ""
    },
    {
      "text": "During a rural health camp screening in India, a 6-year-old boy is evaluated for developmental delay and unusual skeletal features. His parents report that he has a history of frequent eye and vision issues. A genetic enzymatic defect is suspected. Which condition is associated with a defect in the enzyme cystathionine synthase?",
      "options": [
        {
          "label": "A",
          "text": "Hartnup\u2019s disease",
          "correct": false
        },
        {
          "label": "B",
          "text": "Cystinuria",
          "correct": false
        },
        {
          "label": "C",
          "text": "Homocystinuria",
          "correct": true
        },
        {
          "label": "D",
          "text": "Cystathioninuria",
          "correct": false
        }
      ],
      "correct_answer": "C. Homocystinuria",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. C.</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation</li><li>\u2022 :</li><li>\u2022 Option A. Hartnup\u2019s disease: Due to defective absorption of aromatic amino acids from intestine as well as reabsorption from renal tubules due to mutation of SLC6A19 gene encodes the transporter protein (B0AT1) seen in Intestine and renal tubules \u2192excretion of amino acids in urine. Due to deficiency of Tryptophan, Niacin is not produced and so, the presentation is similar to Pellagra.</li><li>\u2022 Option A. Hartnup\u2019s disease:</li><li>\u2022 defective absorption of aromatic amino acids</li><li>\u2022 Option B. Cystinuria: Due to defect/deficiency of transporter system \u2192patients cannot reabsorb cysteine into their bloodstream  \u2192 accumulation of cystine in urine forms crystals and stones \u2192 leads to recurrent nephrolithiasis and obstruction of urine flow \u2192c/f- severe, sudden flank pain, blood and WBC in urine, fever, and finally renal failure.</li><li>\u2022 Option B. Cystinuria:</li><li>\u2022 defect/deficiency of transporter system</li><li>\u2022 Option D. Cystathioninuria: Due to cystathionine deficiency , patient presents with mental retardation, anemia, thrombocytopenia and endocrinopathies. Acquired Cystathioninuria might be due to pyridoxine deficiency, liver diseases and after thyroxine administration.</li><li>\u2022 Option D. Cystathioninuria:</li><li>\u2022 cystathionine deficiency</li></ul>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective:</li><li>\u27a4 Cystathionine synthase is an enzyme critical in the metabolism of methionine, converting homocysteine to cystathionine. A deficiency in this enzyme leads to homocystinuria, a disorder characterized by elevated levels of homocysteine, which can result in developmental delay, skeletal abnormalities, and ocular issues.</li><li>\u27a4 Ref : DM Vasudevan 9/e: p 221.</li><li>\u27a4 Ref</li><li>\u27a4 : DM Vasudevan 9/e: p 221.</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "3e833928",
      "audio": ""
    },
    {
      "text": "A 4-month-old baby boy presents with a 6-day history of fever, cough, breathing difficulty, and Kussmaul respiration. On examination, he appears lethargic and dehydrated, and the mother reports his urine has a distinctive cheesy odor. Urine organic acid analysis indicates increased excretion of 3-hydroxybutyric acid and moderate levels of 3-hydroxy-isovaleric acid. What is the most likely diagnosis?",
      "options": [
        {
          "label": "A",
          "text": "Isovaleric acidemia",
          "correct": true
        },
        {
          "label": "B",
          "text": "Tyrosinemia Type I",
          "correct": false
        },
        {
          "label": "C",
          "text": "Phenylketonuria",
          "correct": false
        },
        {
          "label": "D",
          "text": "Maple syrup urine disease",
          "correct": false
        }
      ],
      "correct_answer": "A. Isovaleric acidemia",
      "question_images": [],
      "explanation_images": [
        "https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/04/03/screenshot-2024-04-03-172139.jpg"
      ],
      "explanation": "<p><strong>Ans. A. Isovaleric acidemia</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation</li><li>\u2022 :</li><li>\u2022 Option B. Hepatorenal Tyrosinemia (Tyrosinemia Type I) is due to a deficiency of enzyme fumarylacetoacetate hydrolase. C/F: mild mental retardation, Cabbage like odour in urine, hypoglycemia liver failure and finally death occurs</li><li>\u2022 Option B. Hepatorenal Tyrosinemia (Tyrosinemia Type I)</li><li>\u2022 Option C. Phenylketonuria: defect in phenylalanine hydroxylase, gives mousy or musty odour.</li><li>\u2022 Option C. Phenylketonuria:</li><li>\u2022 Option D. Maple syrup urine disease: Deficiency of the branched chain ketoacid dehydrogenase results in accumulation of branched chain ketoacids in blood, urine, and tissues. The urine has the maple syrup odour / burnt sugar smell with development of metabolic acidosis.</li><li>\u2022 Option D. Maple syrup urine disease:</li><li>\u2022 branched chain ketoacid dehydrogenase</li><li>\u2022 maple syrup odour</li><li>\u2022 burnt sugar smell</li></ul>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective:</li><li>\u27a4 Isovaleric acidemia is characterized by the inability to properly break down the amino acid leucine, leading to the accumulation of isovaleric acid and related metabolites, including 3-hydroxybutyric acid and 3-hydroxy-isovaleric acid. The distinctive \"sweaty feet\" or cheesy odor of the urine is a classic clinical clue.</li><li>\u27a4 Ref : Harper 30/e: p 309-312.</li><li>\u27a4 Ref</li><li>\u27a4 : Harper 30/e: p 309-312.</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "162abd0f",
      "audio": ""
    },
    {
      "text": "A 7-month-old baby, with a family history of a urea cycle disorder leading to the death of a sibling at 1 year of age, has been diagnosed with the same condition. What is the rationale for administering benzoic acid to individuals with a urea cycle enzyme defect?",
      "options": [
        {
          "label": "A",
          "text": "It provides an alternative route for N 2 excretion through glycine conjugate, hippuric acid",
          "correct": true
        },
        {
          "label": "B",
          "text": "It provides an alternative route for N 2 excretion through the N-acetyl glucuronic acid conjugate kynurenine",
          "correct": false
        },
        {
          "label": "C",
          "text": "It inhibits adenylate deaminase",
          "correct": false
        },
        {
          "label": "D",
          "text": "It neutralized NH 3 in both blood as well as urine",
          "correct": false
        }
      ],
      "correct_answer": "A. It provides an alternative route for N 2 excretion through glycine conjugate, hippuric acid",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. A.</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation</li><li>\u2022 :</li><li>\u2022 Option B. It provides an alternative route for nitrogen (N2) excretion through the N-acetyl glucuronic acid conjugate kynurenine: This option is not accurate; kynurenine is a metabolite in the tryptophan degradation pathway and not directly related to the excretion of nitrogen in the context of urea cycle disorders.</li><li>\u2022 Option</li><li>\u2022 B.</li><li>\u2022 Option C. It inhibits adenylate deaminase: Adenylate deaminase is not directly relevant to the management of urea cycle disorders or the mechanism of action of benzoic acid in these conditions.</li><li>\u2022 Option</li><li>\u2022 C.</li><li>\u2022 Option D. It neutralizes ammonia (NH3) in both blood and urine: Benzoic acid does not neutralize ammonia directly; instead, it provides an alternative pathway for nitrogen excretion by forming hippuric acid with glycine.</li><li>\u2022 Option</li><li>\u2022 D.</li></ul>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective</li><li>\u27a4 :</li><li>\u27a4 In urea cycle disorders, benzoic acid provides an alternative pathway for nitrogen excretion by forming hippuric acid with glycine, thus reducing ammonia levels in the body. This is crucial for managing hyperammonemia resulting from the body's impaired ability to convert ammonia to urea.</li><li>\u27a4 Ref : DM Vasudevan 9/e: page 206.</li><li>\u27a4 Ref : DM Vasudevan 9/e: page 206.</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "e1766eef",
      "audio": ""
    },
    {
      "text": "The Nitrogen sources of UREA are ammonia and arginine. Choose the appropriate response.",
      "options": [
        {
          "label": "A",
          "text": "True",
          "correct": false
        },
        {
          "label": "B",
          "text": "False",
          "correct": true
        },
        {
          "label": "C",
          "text": "Information Insufficient",
          "correct": false
        },
        {
          "label": "D",
          "text": "None of the above",
          "correct": false
        }
      ],
      "correct_answer": "B. False",
      "question_images": [],
      "explanation_images": [
        "https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/04/04/picture80.jpg"
      ],
      "explanation": "<p><strong>Ans. B.</strong></p>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective:</li><li>\u27a4 The urea cycle uses nitrogen from ammonia and aspartate , with ammonia entering through carbamoyl phosphate and aspartate contributing through its conversion to argininosuccinate . Arginine, while an intermediate, is not a primary nitrogen source but is cleaved to produce urea.</li><li>\u27a4 urea cycle</li><li>\u27a4 nitrogen from ammonia and aspartate</li><li>\u27a4 ammonia entering through carbamoyl phosphate</li><li>\u27a4 aspartate</li><li>\u27a4 conversion to argininosuccinate</li><li>\u27a4 Arginine,</li><li>\u27a4 not a primary nitrogen source</li><li>\u27a4 Ref : DM Vasudevan 9/e: p 203.</li><li>\u27a4 Ref</li><li>\u27a4 : DM Vasudevan 9/e: p 203.</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "8dc67c0f",
      "audio": ""
    },
    {
      "text": "A 7-year-old girl has been diagnosed with an inherited metabolic disorder. Her mother is cautioned that consuming \"sugar-free\" products containing aspartame could be harmful to her daughter's health. Based on this advice, which genetic disorder is the girl most likely to have?",
      "options": [
        {
          "label": "A",
          "text": "Hyperornithinemia",
          "correct": false
        },
        {
          "label": "B",
          "text": "Hyperuricemia",
          "correct": false
        },
        {
          "label": "C",
          "text": "Phenylketonuria",
          "correct": true
        },
        {
          "label": "D",
          "text": "Hypervalinemia",
          "correct": false
        }
      ],
      "correct_answer": "C. Phenylketonuria",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. C.</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation</li><li>\u2022 :</li><li>\u2022 Option A. Hyperornithinemia: This condition involves elevated levels of ornithine and is not directly related to aspartame consumption. Treatment- Low protein diet.</li><li>\u2022 Option A. Hyperornithinemia:</li><li>\u2022 Option B. Hyperuricemia: Characterized by elevated uric acid levels, it is not influenced by aspartame intake in the context described. Treatment- Reduce dietary intake of purine and restrict alcohol, uricosuric drugs (decrease the reabsorption of uric acid from kidney tubules) and reduce the urate production by allopurinol (analog of hypoxanthine).</li><li>\u2022 Option B. Hyperuricemia:</li><li>\u2022 Option D. Hypervalinemia: Involving elevated levels of valine, this condition is also not impacted by the consumption of aspartame. Treatment - Restrict valine in diet.</li><li>\u2022 Option D. Hypervalinemia:</li><li>\u2022 -</li></ul>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective:</li><li>\u27a4 Phenylketonuria (PKU) is an inherited metabolic disorder characterized by a deficiency in the enzyme phenylalanine hydroxylase, leading to the accumulation of phenylalanine in the body.</li><li>\u27a4 Ref : Harper 30/e: p304-306</li><li>\u27a4 Ref : Harper 30/e: p304-306</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "8a12fce7",
      "audio": ""
    },
    {
      "text": "Identify which of the following statements is incorrect?",
      "options": [
        {
          "label": "A",
          "text": "Conversion of glycine to serine requires folic acid and B6",
          "correct": false
        },
        {
          "label": "B",
          "text": "Ornithine decarboxylase is the rate limiting step of polyamine synthesis",
          "correct": false
        },
        {
          "label": "C",
          "text": "The transport of one molecule of amino acid and regeneration of GSH requires 2 ATPs in Meister\u2019s Cycle",
          "correct": true
        },
        {
          "label": "D",
          "text": "Proline does not undergo Transamination",
          "correct": false
        }
      ],
      "correct_answer": "C. The transport of one molecule of amino acid and regeneration of GSH requires 2 ATPs in Meister\u2019s Cycle",
      "question_images": [],
      "explanation_images": [
        "https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/04/04/picture90.jpg",
        "https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/04/04/picture100.jpg",
        "https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/04/04/picture11111.jpg"
      ],
      "explanation": "<p><strong>Ans. C. The transport of one molecule of amino acid and regeneration of GSH requires 2 ATPs in Meister\u2019s Cycle</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation</li><li>\u2022 :</li><li>\u2022 Option A. Glycine is converted to Serine by Serine Hydroxymethyl Transferase.</li><li>\u2022 Option A.</li><li>\u2022 Glycine is converted to Serine</li><li>\u2022 Serine Hydroxymethyl Transferase.</li><li>\u2022 Coenzymes required are Folic acid and Pyridoxal Phosphate.</li><li>\u2022 Coenzymes</li><li>\u2022 Folic acid</li><li>\u2022 Pyridoxal Phosphate.</li><li>\u2022 Option B. Polyamines are organic compounds having multiple amino groups . They are:</li><li>\u2022 Option B.</li><li>\u2022 Polyamines</li><li>\u2022 organic compounds</li><li>\u2022 multiple amino groups</li><li>\u2022 Putrescine derived from decarboxylation of Ornithine Spermidine derived from Ornithine and Methionine Spermine derived from Ornithine and Methionine</li><li>\u2022 Putrescine derived from decarboxylation of Ornithine</li><li>\u2022 Spermidine derived from Ornithine and Methionine</li><li>\u2022 Spermine derived from Ornithine and Methionine</li><li>\u2022 Steps of Polyamine synthesis</li><li>\u2022 Steps of Polyamine synthesis</li><li>\u2022 Ornithine is decarboxylated to form putrescine, by the enzyme ornithine decarboxylase, which is the rate limiting step of polyamine synthesis. S-adenosyl Methionine is decarboxylated to form Decarboxylated SAM . Decarboxylated SAM donates 3 carbon atoms and 1 \u03b1-amino group to putrescine to form Spermidine. Decarboxylated SAM donates 3 carbon atoms and 1 \u03b1-amino group to Spermidine to form Spermine.</li><li>\u2022 Ornithine is decarboxylated to form putrescine, by the enzyme ornithine decarboxylase, which is the rate limiting step of polyamine synthesis.</li><li>\u2022 ornithine decarboxylase,</li><li>\u2022 rate limiting step</li><li>\u2022 S-adenosyl Methionine is decarboxylated to form Decarboxylated SAM .</li><li>\u2022 Decarboxylated SAM</li><li>\u2022 Decarboxylated SAM donates 3 carbon atoms and 1 \u03b1-amino group to putrescine to form Spermidine.</li><li>\u2022 Spermidine.</li><li>\u2022 Decarboxylated SAM donates 3 carbon atoms and 1 \u03b1-amino group to Spermidine to form Spermine.</li><li>\u2022 Spermine.</li><li>\u2022 Option D. Amino acid that does not undergo Transamination</li><li>\u2022 Option D.</li><li>\u2022 Amino acid that does not undergo Transamination</li><li>\u2022 Proline Hydroxyproline Threonine Lysine</li><li>\u2022 Proline</li><li>\u2022 Hydroxyproline</li><li>\u2022 Threonine</li><li>\u2022 Lysine</li></ul>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective:</li><li>\u27a4 Meister Cycle, where 3 ATPs needed for transporting one amino acid molecule and regenerating GSH, crucial in absorbing neutral amino acids.</li><li>\u27a4 Meister Cycle,</li><li>\u27a4 3 ATPs</li><li>\u27a4 transporting one amino acid molecule</li><li>\u27a4 regenerating GSH,</li><li>\u27a4 absorbing neutral amino acids.</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "b660d465",
      "audio": ""
    },
    {
      "text": "A newborn present with milky white skin, white hair, and red-appearing eyes. Which enzyme defect is most commonly associated with this disorder?",
      "options": [
        {
          "label": "A",
          "text": "Phenylalanine hydroxylase",
          "correct": false
        },
        {
          "label": "B",
          "text": "NADPH oxidase",
          "correct": false
        },
        {
          "label": "C",
          "text": "Tyrosinase",
          "correct": true
        },
        {
          "label": "D",
          "text": "Homogentisic acid oxidase",
          "correct": false
        }
      ],
      "correct_answer": "C. Tyrosinase",
      "question_images": [
        "https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/04/04/picture12_CnQINfC.jpg"
      ],
      "explanation_images": [
        "https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/04/04/picture14_scyWKAh.jpg"
      ],
      "explanation": "<p><strong>Ans. C. Tyrosinase</strong></p>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective:</li><li>\u27a4 Albinism is most often caused by a defect in the enzyme tyrosinase, leading to a lack of melanin production and the associated clinical presentation of white skin, white hair, and red-appearing eyes.</li><li>\u27a4 Ref : DM Vasudevan 9/e: p 234,238.</li><li>\u27a4 Ref</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "ac413d9a",
      "audio": ""
    },
    {
      "text": "In managing a patient with Maple Syrup Urine Disease (MSUD), dietary restrictions are crucial. Among the following amino acids, which one does NOT need to be restricted in the diet for a patient with MSUD?",
      "options": [
        {
          "label": "A",
          "text": "Methionine",
          "correct": true
        },
        {
          "label": "B",
          "text": "Valine",
          "correct": false
        },
        {
          "label": "C",
          "text": "Leucine",
          "correct": false
        },
        {
          "label": "D",
          "text": "Isoleucine",
          "correct": false
        }
      ],
      "correct_answer": "A. Methionine",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. A.</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation</li><li>\u2022 :</li><li>\u2022 Option B. Valine: As a BCAA, valine needs to be restricted in the diet of MSUD patients.</li><li>\u2022 Option</li><li>\u2022 B. Valine:</li><li>\u2022 Option C. Leucine: Leucine accumulation is particularly toxic in MSUD, necessitating dietary restriction.</li><li>\u2022 Option</li><li>\u2022 C. Leucine:</li><li>\u2022 Option D. Isoleucine: Another BCAA that needs to be limited in the diet of patients with MSUD.</li><li>\u2022 Option</li><li>\u2022 D. Isoleucine:</li></ul>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective:</li><li>\u27a4 Maple Syrup Urine Disease (MSUD) is characterized by a deficiency in the branched-chain \u03b1-keto acid dehydrogenase complex, leading to the accumulation of branched-chain amino acids (BCAAs) and their corresponding keto acids in the blood. The primary amino acids affected are leucine, isoleucine, and valine.</li><li>\u27a4 Ref : DM Vasudevan 9/e: p 230.</li><li>\u27a4 Ref : DM Vasudevan 9/e: p 230.</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "b1eb52e7",
      "audio": ""
    },
    {
      "text": "A 35-year-old male on tuberculosis treatment with isoniazid reports numbness and tingling in his fingers for the past 3 weeks. Laboratory tests reveal low pyridoxal phosphate levels and the presence of xanthurenic acid in urine. Which metabolic pathway's disturbance results in xanthurenic acid excretion?",
      "options": [
        {
          "label": "A",
          "text": "Phenylalanine",
          "correct": false
        },
        {
          "label": "B",
          "text": "Tryptophan",
          "correct": true
        },
        {
          "label": "C",
          "text": "Tyrosine",
          "correct": false
        },
        {
          "label": "D",
          "text": "Histidine",
          "correct": false
        }
      ],
      "correct_answer": "B. Tryptophan",
      "question_images": [],
      "explanation_images": [
        "https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/04/04/picture10_2KRUokD.jpg"
      ],
      "explanation": "<p><strong>Ans. B.</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation</li><li>\u2022 :</li><li>\u2022 Option A. Phenylalanine: Disturbances in phenylalanine metabolism are associated with conditions like phenylketonuria (PKU), not characterized by xanthurenic acid excretion.</li><li>\u2022 Option</li><li>\u2022 A. Phenylalanine:</li><li>\u2022 Option C. Tyrosine: Tyrosine metabolism disturbances lead to different sets of conditions, such as albinism or tyrosinemia, but not to increased xanthurenic acid levels.</li><li>\u2022 Option</li><li>\u2022 C. Tyrosine:</li><li>\u2022 Option D. Histidine: Disturbances in histidine metabolism are associated with conditions like histidinemia, which do not result in xanthurenic acid excretion.</li><li>\u2022 Option</li><li>\u2022 D. Histidine:</li></ul>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective:</li><li>\u27a4 Xanthurenic acid excretion in urine is indicative of a disturbance in the tryptophan metabolism pathway. Isoniazid, an antitubercular drug, can cause vitamin B6 (pyridoxine) deficiency, as it competes with pyridoxal phosphate (the active form of vitamin B6) for binding sites. Vitamin B6 is a cofactor for several enzymes in the tryptophan metabolism pathway. Its deficiency can lead to an accumulation of intermediate metabolites like xanthurenic acid.</li><li>\u27a4 Ref : DM Vasudevan 9/e: p 240.</li><li>\u27a4 Ref</li><li>\u27a4 : DM Vasudevan 9/e: p 240.</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "d71c5ce7",
      "audio": ""
    },
    {
      "text": "A 37-year-old male visits a dermatology clinic in India with white patches on the dorsal aspect of his left hand, progressively worsening over the past 3 months. Which enzyme is essential for melanin synthesis, possibly deficient in this patient?",
      "options": [
        {
          "label": "A",
          "text": "Tyrosine Hydroxylase",
          "correct": false
        },
        {
          "label": "B",
          "text": "Homogentisate Oxidase",
          "correct": false
        },
        {
          "label": "C",
          "text": "Tyrosine Transaminase",
          "correct": false
        },
        {
          "label": "D",
          "text": "Tyrosinase",
          "correct": true
        }
      ],
      "correct_answer": "D. Tyrosinase",
      "question_images": [],
      "explanation_images": [
        "https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/04/04/picture7_pW8DEa3.jpg"
      ],
      "explanation": "<p><strong>Ans. D.</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation</li><li>\u2022 :</li><li>\u2022 Option A. Tyrosine Hydroxylase: Tyrosine is hydroxylated to dihydroxyphenylalanine (DOPA) by tyrosine hydroxylase, which requires BH4 and NADPH. Tyrosine hydroxylase is present in adrenal medulla and the DOPA thus generated is used for catecholamine synthesis.</li><li>\u2022 Option A. Tyrosine Hydroxylase:</li><li>\u2022 used for catecholamine synthesis.</li><li>\u2022 Option B Homogentisate Oxidase \u2192Alkaptonuria (AR inheritance) \u2192results in excretion of homogentisic acid in urine. C/F- blackening of urine on standing, Ochronosis and Black pigments over joint cavities to produce arthritis.</li><li>\u2022 Option B Homogentisate Oxidase</li><li>\u2022 C/F-</li><li>\u2022 Option C. Tyrosine Transaminase: Deficiency leads to Oculocutaneous Tyrosinemia (Tyrosinemia Type II), C/F - Mental retardation, keratosis of palmar surface, painful corneal lesions and photophobia with increased excretion of tyrosine and tyramine in urine. A diet low in protein is advised.</li><li>\u2022 Option C. Tyrosine Transaminase:</li><li>\u2022 C/F</li></ul>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective:</li><li>\u27a4 Melanin synthesis requires the enzyme tyrosinase, which catalyzes the oxidation of tyrosine to DOPA and DOPAquinone, key steps in the production of melanin. A deficiency or functional impairment in tyrosinase can lead to conditions like vitiligo or albinism, characterized by the loss of pigmentation in the skin.</li><li>\u27a4 Ref : DM Vasudevan 9/e: p 239.</li><li>\u27a4 Ref</li><li>\u27a4 : DM Vasudevan 9/e: p 239.</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "badd9915",
      "audio": ""
    },
    {
      "text": "A 3-month-old infant with pale skin and blonde hair is presented to the pediatric outpatient department by her parents. The infant has two siblings with complete albinism, while both parents are phenotypically normal. Based on this family history and the clinical presentation, which statement is correct regarding albinism?",
      "options": [
        {
          "label": "A",
          "text": "Increased tyrosinase activity will be observed in melanocytes",
          "correct": false
        },
        {
          "label": "B",
          "text": "It results in photophobia",
          "correct": true
        },
        {
          "label": "C",
          "text": "Mental retardation is the main characteristic feature in albinism",
          "correct": false
        },
        {
          "label": "D",
          "text": "Skin has high pigmentation in albinism",
          "correct": false
        }
      ],
      "correct_answer": "B. It results in photophobia",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. B.</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation</li><li>\u2022 :</li><li>\u2022 Option A. Increased tyrosinase activity: Incorrect. Albinism is usually associated with decreased or absent activity of tyrosinase in melanocytes, not increased activity.</li><li>\u2022 Option A. Increased tyrosinase activity:</li><li>\u2022 Option C. Mental retardation: Incorrect. Albinism does not inherently affect cognitive function; mental retardation is not a characteristic feature of albinism.</li><li>\u2022 Option</li><li>\u2022 C. Mental retardation:</li><li>\u2022 Option D. Skin has high pigmentation: Incorrect. Albinism is defined by reduced or absent pigmentation in the skin.</li><li>\u2022 Option</li><li>\u2022 D. Skin has high pigmentation:</li></ul>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective:</li><li>\u27a4 Albinism is characterized by a deficiency or absence of melanin pigmentation and can often result in photophobia due to the lack of melanin in the iris and retinal pigment epithelium. This causes increased light penetration into the eye, leading to discomfort in bright environments.</li><li>\u27a4 Ref : Vasudevan 9/ed: p 238.</li><li>\u27a4 Ref</li><li>\u27a4 : Vasudevan 9/ed: p 238.</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "dc67841e",
      "audio": ""
    },
    {
      "text": "A 35-year-old woman in India presents with fever, left flank pain radiating to the leg, and acute urinary retention. She has a similar past episode six months ago. On examination, she's tender in the abdominal region and appears anemic. Urinalysis reveals RBCs, pus cells, WBC casts, hexagonal crystals, and amino acids. What is the most likely diagnosis?",
      "options": [
        {
          "label": "A",
          "text": "\u200b\u200b\u200b Cystinosis",
          "correct": false
        },
        {
          "label": "B",
          "text": "Cystinuria",
          "correct": true
        },
        {
          "label": "C",
          "text": "Renal Fanconi syndrome",
          "correct": false
        },
        {
          "label": "D",
          "text": "Cystathioninuria",
          "correct": false
        }
      ],
      "correct_answer": "B. Cystinuria",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. B.</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation</li><li>\u2022 :</li><li>\u2022 Option A. Cystinosis: This is a lysosomal storage disorder with accumulation of excess cystine crystals in eyes and kidneys. Due to mutation in the gene CTNS, which codes for the protein cystinosin, the lysosomal cystine transporter. Symptoms: excessive urination, poor growth, photophobia and renal failure by age 6.</li><li>\u2022 Option A. Cystinosis:</li><li>\u2022 Option C. Renal Fanconi syndrome: Caused by Cystinosis with loss of large amounts of salt and other minerals in urine. It is an example of RTA Type 2, characterized by increased urinary excretion of glucose, amino acids, bicarbonate, phosphate and salt wasting.</li><li>\u2022 Option C. Renal Fanconi syndrome:</li><li>\u2022 Option D. Cystathioninuria: Due to cystathionase deficiency, presents with mental retardation, anemia, thrombocytopenia and endocrinopathies. Acquired Cystathioninuria might be due to pyridoxine deficiency, liver diseases and after thyroxine administration.</li><li>\u2022 Option D. Cystathioninuria:</li></ul>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective:</li><li>\u27a4 The presence of characteristic hexagonal crystals in the urine along with RBCs, pus cells, and WBC casts suggests a stone-forming condition. Cystinuria is a genetic disorder characterized by defective renal tubular reabsorption of certain amino acids including cystine, leading to the formation of cystine stones, which can manifest with urinary retention and flank pain due to obstruction.</li><li>\u27a4 Ref : Harper 30/e:  p 301-302.</li><li>\u27a4 Ref : Harper 30/e:  p 301-302.</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "fb66459e",
      "audio": ""
    },
    {
      "text": "At a Health fair, a nutritionist sets up an interactive booth focusing on amino acids and their derivatives, highlighting their roles in nutrition and health. One of the informational posters prompts visitors to match lesser-known names of amino acid derivatives with their more common terms. A visitor, intrigued by the challenge, points to \"N-Methyl Glycine\" on the poster. She asks the nutritionist for its commonly known name. How should the nutritionist respond?",
      "options": [
        {
          "label": "A",
          "text": "Ergothioneine",
          "correct": false
        },
        {
          "label": "B",
          "text": "Sarcosine",
          "correct": true
        },
        {
          "label": "C",
          "text": "Carnosine",
          "correct": false
        },
        {
          "label": "D",
          "text": "Betaine",
          "correct": false
        }
      ],
      "correct_answer": "B. Sarcosine",
      "question_images": [],
      "explanation_images": [
        "https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/04/03/screenshot-2024-04-03-181622.jpg"
      ],
      "explanation": "<p><strong>Ans. B.</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation</li><li>\u2022 :</li><li>\u2022 Option A. Ergothioneine: This is a derivative of histidine, not related to N-Methyl Glycine.</li><li>\u2022 Option</li><li>\u2022 A. Ergothioneine:</li><li>\u2022 Option C. Carnosine: This dipeptide consists of beta-alanine and histidine, differing significantly from N-Methyl Glycine.</li><li>\u2022 Option</li><li>\u2022 C. Carnosine:</li><li>\u2022 Option D. Betaine: Derived from choline, betaine serves as a methyl donor in various biochemical processes but is not synonymous with N-Methyl Glycine.</li><li>\u2022 Option</li><li>\u2022 D. Betaine:</li></ul>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective:</li><li>\u27a4 N-Methyl Glycine is more commonly known as sarcosine. It is a derivative of glycine, where a methyl group is added to the amino acids nitrogen atom. Sarcosine plays various roles in biological systems, including in metabolism and nutrition.</li><li>\u27a4 Ref : Harper 30/e: p 284.</li><li>\u27a4 Ref : Harper 30/e: p 284.</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "c5ccee4d",
      "audio": ""
    }
  ]
}